锌离子对蛋白磷酸酯酶2A的调节及其在阿尔茨海默病中的作用
|
摘要
阿尔茨海默病（Alzheimer’s Disease, AD）是最常见的老年性痴呆症，其主要病理学改变是脑内神经元纤维缠结（NFTs）和老年斑(SP)的形成。NFTs的主要成分是过度磷酸化的微管相关蛋白tau,异常磷酸化的tau丧失其促微管组装和稳定微管的功能,并聚集成为成对螺旋丝（PHF），最终导致NFT的形成、突触的退变和神经元的丢失,在AD的发生、发展中起关键作用。而tau的磷酸化主要受相关蛋白激酶（protein kinases, PK）和蛋白磷酸酯酶（protein phosphatases,PP）的调节。大量的研究事实表明，蛋白磷酸酯酶2A(PP2A)的活性在阿尔茨海默病人脑中下降并参与AD样tau蛋白异常磷酸化的形成，但导致PP2A活性下降的上游因素和机制尚未阐明。
锌（Zn）离子，是脑内含量较为丰富的微量元素之一，参与神经传导，抗氧化反应，并调节多种酶和生长因子的活性。大量研究结果表明，胞外锌离子水平增高可导致多种蛋白质发生酪氨酸磷酸化修饰。前期研究结果显示PP2A催化亚单位酪氨酸307位点（Y307）磷酸化后可明显抑制PP2A活性，而在AD易感脑区锌离子水平增高，提示锌离子可能参与了AD脑内PP2A活性的下调而促进tau蛋白过度磷酸化。且到目前为止Zn对PP2A的调节及机制尚无报道。
我们在本研究中重点探讨了锌离子对PP2A的调节及其在tau过度磷酸化中的作用，并且从分子水平解释了Zn对PP2A的直接和间接抑制作用机制。主要结果如下：
第一部分
锌离子通过激活Src途径抑制PP2A活性和导致tau蛋白过度磷酸化
蛋白磷酸酯酶2A(PP2A)的活性在阿尔茨海默病（AD）人脑中下降并参与AD样tau蛋白异常磷酸化的形成，但导致PP2A活性下降的上游因素和机制尚未阐明。有文献报道显示，PP2A催化亚基的酪氨酸307位点（Y307）磷酸化修饰是导致PP2A失活的直接原因，但何种机制促使PP2A发生失活性修饰还不清楚。大量研究结果表明，胞外锌离子水平增高可导致多种蛋白质发生酪氨酸磷酸化修饰，而在AD易感脑区锌离子水平增高，提示锌离子可能参与了AD脑内PP2A活性的下调而促进tau蛋白过度磷酸化。
【目的】阐明锌离子是否通过调节PP2A活性促进tau蛋白异常过度磷酸化及调节PP2A活性的机制。
【材料和方法】实验在整体和细胞水平进行。整体水平采用雄性SD大鼠，侧脑室定位注射硫酸锌，分组如下：生理盐水对照组、30mM硫酸锌给药组，30mM硫酸锌给药+锌离子特异性螯合剂CQ腹腔注射组。在侧脑室注射6天后，麻醉取脑分离海马组织匀浆，用免疫印迹检测tau磷酸化水平的变化，以及PP2Ac Y307磷酸化水平的变化,检测PP2A的活性；细胞水平采用小鼠成神经瘤N2a细胞系，用100μM硫酸锌处理3小时后提取蛋白，同样方法检测PP2Ac Y307磷酸化及tau磷酸化水平。同时在细胞水平给予PP2或DES预孵育30min或转染野生型PP2A和突变性PP2A，在用用100μM硫酸锌处理3小时后提取蛋白，同样方法检测PP2Ac磷酸化及tau磷酸化水平。在转基因动物水平，我们采用转人tau的转基因小鼠，锌离子螯合剂CQ灌胃35天，检测PP2Ac磷酸化及tau磷酸化水平及可溶性tau和不溶性tau的变化情况。
【结果】将锌离子直接注射入整体动物侧脑室，6天后海马PP2Ac Y307磷酸化水平明显增高，伴随PP2A活性下降，tau蛋白在多个丝氨酸/苏氨酸位点如Ser214、Thr205、Ser396、Ser404发生过度磷酸化；给动物同时腹腔注射锌离子螯合剂CQ,则可部分逆转PP2Ac Y307磷酸化水平和PP2A活性的抑制。用硫酸锌处理小鼠成神经瘤N2a细胞，同样导致PP2Ac发生酪氨酸磷酸化修饰和活性下降，tau蛋白在多个位点发生过度磷酸化,伴随Src失活性磷酸化位点酪氨酸529（Tyr529）磷酸化水平降低，Src激活。给予锌同时给予PP2A的激动剂或过表达野生型PP2A可逆转锌导致的PP2Ac活性下降以及tau蛋白的过度磷酸化。给予Src家族的特异性抑制剂PP2同样可部分逆转PP2Ac Y307磷酸化和PP2A活性的抑制以及tau蛋白的磷酸化。转基因小鼠的给予锌离子螯合剂CQ灌胃后，Src活性抑制，PP2Ac Y307磷酸化水平降低，PP2A活性抑制和tau蛋白磷酸化被逆转，伴随海马内不可溶性tau水平明显下降，
【结论】锌离子可通过激活Src而对PP2A进行酪氨酸磷酸化修饰下调PP2A活性,从而导致tau蛋白发生过度磷酸化，促进AD样病变的形成。干预tau转基因小鼠脑内锌离子水平可上调PP2A活性并降低tau蛋白的磷酸化水平。因此干预锌离子水平有可能成为在体上调PP2A活性的新策略。
第二部分
锌离子体外直接抑制PP2A活性及机制研究
我们已经在第一部分阐明锌离子在整体动物脑和细胞内可通过激活Src而使PP2AY307磷酸化失活和tau蛋白过度磷酸化。那么在体外锌离子对PP2A是否有直接调节作用？其内在机制是什么到目前为止尚无报道。
【目的】阐明锌离子直接调节PP2A活性及其内在机制。
【材料和方法】收集培养的N2a细胞并裂解，在不加入ATP的情况下直接将细胞裂解液和100μM硫酸锌或10nM冈田酸（OA）孵育0，5，15，30min，用免疫印迹检测tau磷酸化水平的变化。同样的方法用不同浓度（0，10，50，100μM）硫酸锌与细胞裂解液共孵育不同时间（0，5，15，30，60min），检测PP2A活性。构建不同片段的PP2Ac原核表达质粒并纯化，将纯化的GST-PP2A_(1-50)、PP2A_(51-270)和PP2A_(271-309)分别和100μM硫酸锌孵育，检测PP2A活性。最后我们用亲和层析柱（IDA）预先孵育硫酸锌或不孵育硫酸锌，分别让纯化的GST-PP2A_(1-50)、GST-PP2A_(51-270)和GST-PP2A_(271-309)自然流过IDA柱，然后用EDTA洗脱，收集不同组分的液体用免疫印迹检测GST的变化以确定不同片段PP2Ac与Zn的结合情况。
【结果】将硫酸锌和细胞裂解液共孵育可延缓tau蛋白发生去磷酸化的进程，共孵育15min时已和强PP2A抑制剂冈田酸具有同等的抑制tau蛋白去磷酸化的效果，同时随着时间和硫酸锌浓度的变化，PP2A的活性被抑制，在10μM，30min时到达最低水平，抑制率下降30%。而且给予硫酸锌10μM时，PP2A的抑制效应有时间依赖性。说明在体外锌离子直接抑制PP2A活性。为了进一步确定锌离子对PP2A的直接抑制作用，将截断的PP2A与锌离子直接孵育发现锌离子可以直接抑制GST-PP2A_(51-270)片段的活性。通过IDA实验发现，锌离子仅和GST-PP2A_(51-270)有直接结合作用。
【结论】在体外，锌离子通过与PP2A_(51-270)结合发挥直接抑制PP2A活性的作用，这为阐明PP2A活性调节的全新途径提供了重要线索，并为AD的防治提供新靶点。
Alzheimer’s Disease is one of the most common dementia which is characterized byextracellular senile plaques (SP) and intracellular neurofibrillary tangles (NTFs). NTFs arecomposed of abnormal hyperphosphorylated microtubule-associated protein tau. Abnormalhyperphosphorylated tau loses the ability of promoting microtubules assembly and stabilityand forms paired helical filament (PHF), inducing synapses degeneration and neuronloss.Thus, tau hyperphosphorylation plays an important role in the process of AD. As aphosphoprotein, tau phosphorylation is regulated by tau kinases such as GlycogenSynthesis Kinase3β (GSK-3β) and tau phosphatases such as Protein Phosphatase2A(PP2A). Previous reports showed that PP2A is down-regulated in AD brain, but theupstream factor and underlying mechanism is still unknown.
Zinc,one of the most important trace elements,plays an critical role in neuronaltransduction, anti-oxidation reaction and regulation of the activity of many enzymes andgrowth factors. Previous studies imply that the elavated extracellular zinc levels which isobserved in AD brain could induce tyrosine phosphorylation, and tyrosine phosphorylationat PP2A Y307site may inhibit PP2A potently, suggesting that zinc may take part in theregulation of PP2A activity and induces tau hyperphosphorylation. Till now, the regulationof zinc on PP2Aand the underlying mechanisms reamain unclarified.
In the present study, we aimed to investigate the role of zinc in PP2A regulation and tauhyperphosphorylation,discussed the effect of zinc chelator CQ on tauopathy in tautransgenic mice. We also explored the underlying mechanisms of zinc regulation on PP2Aindirectly or directly. The main findings are as following:
Part I
Zinc induces protein phosphatase2A inactivation and tauhyperphosphorylation through Src dependent PP2A (tyrosine307)phosphorylation
The activity of protein phosphatase2A (PP2A) is down-regulated and promotes thehyperphosphorylation of tau in the brains of Alzheimer’s Disease (AD), but the mechanismfor PP2A inactivation has not been elucidated. We have reported that PP2Aphosphorylation at tyrosine307(Y307) is involved in PP2A inactivation. Here, we furtherstudied the upstream mechanisms for PP2A phosphorylation and inactivation. We foundthat zinc, a heavy metal ion that is widely distributed in the normal brain and accumulatedin the susceptible regions of AD brain, participates the inhibition of PP2A and tauhyperphosphorylation.
【Aim】To explore the role zinc in PP2A regulation and tauopathy, and disclose theupstream factors.
【Materials and Methods】The experiments were performed on the animal and cell levels.For the brain zinc injection, SD rats were deeply anesthetized and divided intoexperimental group for lateral ventricular injection with zinc sulfate (10mM,5μl) andcontrol group for injection with PBS (5μl). The experimental group was further dividedinto two groups with or without treatment of zinc chelator CQ (Intraperitoneal injection,30mg/kg/48h). One day or six days after the injection, the rats were sacrificed and thehippocampus was homogenized and then detect the phosphorylation site of tau PP2A andthe activity of PP2A. For the cell experiments, N2a cell were treated with100μM zincsulfate for3hours, with or without pre-incubation of zinc chelator CQ (10μM), Srcinhibitor PP-2(10μM), IGF-1R inhibitor AG1024(10μM), EGFR inhibitor AG1478(10 μM), or PP2Ac agonist DES (10nM) for30min, or transfected with PP2A Y307F orwtPP2A for24h, at the end of incubation, the cells were harvested for detecting thephosphorylation level of tau, PP2A and Src and the activity of PP2A. For brain zincchelating in hTau mice, animals were treated with CQ (30mg/kg/d by oral gavage), orvehicle solution at9months of age for a total period of35days. Then the mice weresacrificed and the brains were isolated, half of the hippocampus was homogenized forfurther biochemistry detections of the phosphorylation level of tau, PP2A and Src and theactivity of PP2A, the other hemisphere was frozen and cryoprotected forimmunohistochemistry.
【Results】We found that zinc could induce PP2A inhibition, phosphorylation of PP2A atY307and tau hyperphosphorylation both in rat brains and cultured N2a cells, while zincchelating prevented these changes completely. Up-regulation of PP2A chemically orgenetically attenuated zinc-induced tau hyperphosphorylation, whereas mutation of Y307to phenylalanine (F) abolished the zinc-induced tyrosine phosphorylation and inactivationof PP2A. Zinc could activate Src, while PP2, a specific Src family kinases (SFKs) inhibitor,attenuated zinc-induced PP2A phosphorylation and inactivation, indicating that zincinduces PP2A Y307phosphorylation and inactivation through Src activation. In human tautransgenic mice, zinc chelator rescued PP2Aactivity, prevented Src activation, and reducedhyperphosphorylated and insoluble tau levels.
【Conclusion】 Zinc induces protein phosphatase2A inactivation and tauhyperphosphorylation through Src-dependent pathway, regulation of zinc homeostasis maybe a promising therapeutics for AD and the related tauopathies.
PartⅡ
Zinc inhibits Protein Phosphatase2A directly in vitro
Previous study indicated that zinc induces protein phosphatase2A (PP2A) inactivation andtau hyperphosphorylation through PP2A(tyrosine307) phosphorylation in cells and brains,but whether or not zinc ion has a direct inhibitory effect on PP2Ais not elucidated.
【Aim】To explored the direct interaction and effect of zinc on PP2Ain vitro.
【Materials and Methods】N2a cell lysates were incubated with100μM zinc sulfate or10nM okadaic acid (OA) for5,15,30min at30°C,then the tau phosphorylation level wasdetected by Western blotting; For the analysis of time and concentration dependent changeof PP2A activity in zinc-incubated cell lysates, N2a cell lysates were incubated with0,10,50,100μM zinc sulfate for30min, or with10μM zinc sulfate for0,10,30,60min at30°C. At the end of incubation, the lysate were collected for PP2A activity assay. For theanalysis of zinc interaction site, different fragments of PP2Ac (GST-PP2A_(1-50)、PP2AR51-270Rand PP2AR_(271-309)R were expressed and purified, and then incubated with or without100μMzinc. The PP2A activities were detected.For the zinc binding assay, IDA-agarose wasincubated with or without Zn~(2+)PPfor30min and added with GST-PP2AcR(1-50)R,GST-PP2AcR_((51-270))Ror GST-PP2AcR(271-309)Rproteins separately at room temperature for30min. After the incubation, the proteins were washed with different buffers, the elutionswere collected for Western blotting by using antibody against GST.
【Results】The results showed that zinc mimic the inhibitory effect of oadaic acid (OA) onPP2A and prevented tau dephosphorylation in N~2a cell lysates. PP2A activity assay resultindicated that low concentration (10μM) of zinc inhibited PP2A directly. FurtherZn~(2-)PP-IDA-Agarose Affinity Binding Assay showed that zinc bound to and inhibitedPP2Ac_((51-270))but not PP2Ac_((1-50))Rand PP2Ac_((271-309))Rsegement directly. 【Conclusion】Zinc inhibits PP2Adirectly through binding to PP2Ac_((51-270))Rin vitro.
锌（Zn）离子，是脑内含量较为丰富的微量元素之一，参与神经传导，抗氧化反应，并调节多种酶和生长因子的活性。大量研究结果表明，胞外锌离子水平增高可导致多种蛋白质发生酪氨酸磷酸化修饰。前期研究结果显示PP2A催化亚单位酪氨酸307位点（Y307）磷酸化后可明显抑制PP2A活性，而在AD易感脑区锌离子水平增高，提示锌离子可能参与了AD脑内PP2A活性的下调而促进tau蛋白过度磷酸化。且到目前为止Zn对PP2A的调节及机制尚无报道。
我们在本研究中重点探讨了锌离子对PP2A的调节及其在tau过度磷酸化中的作用，并且从分子水平解释了Zn对PP2A的直接和间接抑制作用机制。主要结果如下：
第一部分
锌离子通过激活Src途径抑制PP2A活性和导致tau蛋白过度磷酸化
蛋白磷酸酯酶2A(PP2A)的活性在阿尔茨海默病（AD）人脑中下降并参与AD样tau蛋白异常磷酸化的形成，但导致PP2A活性下降的上游因素和机制尚未阐明。有文献报道显示，PP2A催化亚基的酪氨酸307位点（Y307）磷酸化修饰是导致PP2A失活的直接原因，但何种机制促使PP2A发生失活性修饰还不清楚。大量研究结果表明，胞外锌离子水平增高可导致多种蛋白质发生酪氨酸磷酸化修饰，而在AD易感脑区锌离子水平增高，提示锌离子可能参与了AD脑内PP2A活性的下调而促进tau蛋白过度磷酸化。
【目的】阐明锌离子是否通过调节PP2A活性促进tau蛋白异常过度磷酸化及调节PP2A活性的机制。
【材料和方法】实验在整体和细胞水平进行。整体水平采用雄性SD大鼠，侧脑室定位注射硫酸锌，分组如下：生理盐水对照组、30mM硫酸锌给药组，30mM硫酸锌给药+锌离子特异性螯合剂CQ腹腔注射组。在侧脑室注射6天后，麻醉取脑分离海马组织匀浆，用免疫印迹检测tau磷酸化水平的变化，以及PP2Ac Y307磷酸化水平的变化,检测PP2A的活性；细胞水平采用小鼠成神经瘤N2a细胞系，用100μM硫酸锌处理3小时后提取蛋白，同样方法检测PP2Ac Y307磷酸化及tau磷酸化水平。同时在细胞水平给予PP2或DES预孵育30min或转染野生型PP2A和突变性PP2A，在用用100μM硫酸锌处理3小时后提取蛋白，同样方法检测PP2Ac磷酸化及tau磷酸化水平。在转基因动物水平，我们采用转人tau的转基因小鼠，锌离子螯合剂CQ灌胃35天，检测PP2Ac磷酸化及tau磷酸化水平及可溶性tau和不溶性tau的变化情况。
【结果】将锌离子直接注射入整体动物侧脑室，6天后海马PP2Ac Y307磷酸化水平明显增高，伴随PP2A活性下降，tau蛋白在多个丝氨酸/苏氨酸位点如Ser214、Thr205、Ser396、Ser404发生过度磷酸化；给动物同时腹腔注射锌离子螯合剂CQ,则可部分逆转PP2Ac Y307磷酸化水平和PP2A活性的抑制。用硫酸锌处理小鼠成神经瘤N2a细胞，同样导致PP2Ac发生酪氨酸磷酸化修饰和活性下降，tau蛋白在多个位点发生过度磷酸化,伴随Src失活性磷酸化位点酪氨酸529（Tyr529）磷酸化水平降低，Src激活。给予锌同时给予PP2A的激动剂或过表达野生型PP2A可逆转锌导致的PP2Ac活性下降以及tau蛋白的过度磷酸化。给予Src家族的特异性抑制剂PP2同样可部分逆转PP2Ac Y307磷酸化和PP2A活性的抑制以及tau蛋白的磷酸化。转基因小鼠的给予锌离子螯合剂CQ灌胃后，Src活性抑制，PP2Ac Y307磷酸化水平降低，PP2A活性抑制和tau蛋白磷酸化被逆转，伴随海马内不可溶性tau水平明显下降，
【结论】锌离子可通过激活Src而对PP2A进行酪氨酸磷酸化修饰下调PP2A活性,从而导致tau蛋白发生过度磷酸化，促进AD样病变的形成。干预tau转基因小鼠脑内锌离子水平可上调PP2A活性并降低tau蛋白的磷酸化水平。因此干预锌离子水平有可能成为在体上调PP2A活性的新策略。
第二部分
锌离子体外直接抑制PP2A活性及机制研究
我们已经在第一部分阐明锌离子在整体动物脑和细胞内可通过激活Src而使PP2AY307磷酸化失活和tau蛋白过度磷酸化。那么在体外锌离子对PP2A是否有直接调节作用？其内在机制是什么到目前为止尚无报道。
【目的】阐明锌离子直接调节PP2A活性及其内在机制。
【材料和方法】收集培养的N2a细胞并裂解，在不加入ATP的情况下直接将细胞裂解液和100μM硫酸锌或10nM冈田酸（OA）孵育0，5，15，30min，用免疫印迹检测tau磷酸化水平的变化。同样的方法用不同浓度（0，10，50，100μM）硫酸锌与细胞裂解液共孵育不同时间（0，5，15，30，60min），检测PP2A活性。构建不同片段的PP2Ac原核表达质粒并纯化，将纯化的GST-PP2A_(1-50)、PP2A_(51-270)和PP2A_(271-309)分别和100μM硫酸锌孵育，检测PP2A活性。最后我们用亲和层析柱（IDA）预先孵育硫酸锌或不孵育硫酸锌，分别让纯化的GST-PP2A_(1-50)、GST-PP2A_(51-270)和GST-PP2A_(271-309)自然流过IDA柱，然后用EDTA洗脱，收集不同组分的液体用免疫印迹检测GST的变化以确定不同片段PP2Ac与Zn的结合情况。
【结果】将硫酸锌和细胞裂解液共孵育可延缓tau蛋白发生去磷酸化的进程，共孵育15min时已和强PP2A抑制剂冈田酸具有同等的抑制tau蛋白去磷酸化的效果，同时随着时间和硫酸锌浓度的变化，PP2A的活性被抑制，在10μM，30min时到达最低水平，抑制率下降30%。而且给予硫酸锌10μM时，PP2A的抑制效应有时间依赖性。说明在体外锌离子直接抑制PP2A活性。为了进一步确定锌离子对PP2A的直接抑制作用，将截断的PP2A与锌离子直接孵育发现锌离子可以直接抑制GST-PP2A_(51-270)片段的活性。通过IDA实验发现，锌离子仅和GST-PP2A_(51-270)有直接结合作用。
【结论】在体外，锌离子通过与PP2A_(51-270)结合发挥直接抑制PP2A活性的作用，这为阐明PP2A活性调节的全新途径提供了重要线索，并为AD的防治提供新靶点。
Alzheimer’s Disease is one of the most common dementia which is characterized byextracellular senile plaques (SP) and intracellular neurofibrillary tangles (NTFs). NTFs arecomposed of abnormal hyperphosphorylated microtubule-associated protein tau. Abnormalhyperphosphorylated tau loses the ability of promoting microtubules assembly and stabilityand forms paired helical filament (PHF), inducing synapses degeneration and neuronloss.Thus, tau hyperphosphorylation plays an important role in the process of AD. As aphosphoprotein, tau phosphorylation is regulated by tau kinases such as GlycogenSynthesis Kinase3β (GSK-3β) and tau phosphatases such as Protein Phosphatase2A(PP2A). Previous reports showed that PP2A is down-regulated in AD brain, but theupstream factor and underlying mechanism is still unknown.
Zinc,one of the most important trace elements,plays an critical role in neuronaltransduction, anti-oxidation reaction and regulation of the activity of many enzymes andgrowth factors. Previous studies imply that the elavated extracellular zinc levels which isobserved in AD brain could induce tyrosine phosphorylation, and tyrosine phosphorylationat PP2A Y307site may inhibit PP2A potently, suggesting that zinc may take part in theregulation of PP2A activity and induces tau hyperphosphorylation. Till now, the regulationof zinc on PP2Aand the underlying mechanisms reamain unclarified.
In the present study, we aimed to investigate the role of zinc in PP2A regulation and tauhyperphosphorylation,discussed the effect of zinc chelator CQ on tauopathy in tautransgenic mice. We also explored the underlying mechanisms of zinc regulation on PP2Aindirectly or directly. The main findings are as following:
Part I
Zinc induces protein phosphatase2A inactivation and tauhyperphosphorylation through Src dependent PP2A (tyrosine307)phosphorylation
The activity of protein phosphatase2A (PP2A) is down-regulated and promotes thehyperphosphorylation of tau in the brains of Alzheimer’s Disease (AD), but the mechanismfor PP2A inactivation has not been elucidated. We have reported that PP2Aphosphorylation at tyrosine307(Y307) is involved in PP2A inactivation. Here, we furtherstudied the upstream mechanisms for PP2A phosphorylation and inactivation. We foundthat zinc, a heavy metal ion that is widely distributed in the normal brain and accumulatedin the susceptible regions of AD brain, participates the inhibition of PP2A and tauhyperphosphorylation.
【Aim】To explore the role zinc in PP2A regulation and tauopathy, and disclose theupstream factors.
【Materials and Methods】The experiments were performed on the animal and cell levels.For the brain zinc injection, SD rats were deeply anesthetized and divided intoexperimental group for lateral ventricular injection with zinc sulfate (10mM,5μl) andcontrol group for injection with PBS (5μl). The experimental group was further dividedinto two groups with or without treatment of zinc chelator CQ (Intraperitoneal injection,30mg/kg/48h). One day or six days after the injection, the rats were sacrificed and thehippocampus was homogenized and then detect the phosphorylation site of tau PP2A andthe activity of PP2A. For the cell experiments, N2a cell were treated with100μM zincsulfate for3hours, with or without pre-incubation of zinc chelator CQ (10μM), Srcinhibitor PP-2(10μM), IGF-1R inhibitor AG1024(10μM), EGFR inhibitor AG1478(10 μM), or PP2Ac agonist DES (10nM) for30min, or transfected with PP2A Y307F orwtPP2A for24h, at the end of incubation, the cells were harvested for detecting thephosphorylation level of tau, PP2A and Src and the activity of PP2A. For brain zincchelating in hTau mice, animals were treated with CQ (30mg/kg/d by oral gavage), orvehicle solution at9months of age for a total period of35days. Then the mice weresacrificed and the brains were isolated, half of the hippocampus was homogenized forfurther biochemistry detections of the phosphorylation level of tau, PP2A and Src and theactivity of PP2A, the other hemisphere was frozen and cryoprotected forimmunohistochemistry.
【Results】We found that zinc could induce PP2A inhibition, phosphorylation of PP2A atY307and tau hyperphosphorylation both in rat brains and cultured N2a cells, while zincchelating prevented these changes completely. Up-regulation of PP2A chemically orgenetically attenuated zinc-induced tau hyperphosphorylation, whereas mutation of Y307to phenylalanine (F) abolished the zinc-induced tyrosine phosphorylation and inactivationof PP2A. Zinc could activate Src, while PP2, a specific Src family kinases (SFKs) inhibitor,attenuated zinc-induced PP2A phosphorylation and inactivation, indicating that zincinduces PP2A Y307phosphorylation and inactivation through Src activation. In human tautransgenic mice, zinc chelator rescued PP2Aactivity, prevented Src activation, and reducedhyperphosphorylated and insoluble tau levels.
【Conclusion】 Zinc induces protein phosphatase2A inactivation and tauhyperphosphorylation through Src-dependent pathway, regulation of zinc homeostasis maybe a promising therapeutics for AD and the related tauopathies.
PartⅡ
Zinc inhibits Protein Phosphatase2A directly in vitro
Previous study indicated that zinc induces protein phosphatase2A (PP2A) inactivation andtau hyperphosphorylation through PP2A(tyrosine307) phosphorylation in cells and brains,but whether or not zinc ion has a direct inhibitory effect on PP2Ais not elucidated.
【Aim】To explored the direct interaction and effect of zinc on PP2Ain vitro.
【Materials and Methods】N2a cell lysates were incubated with100μM zinc sulfate or10nM okadaic acid (OA) for5,15,30min at30°C,then the tau phosphorylation level wasdetected by Western blotting; For the analysis of time and concentration dependent changeof PP2A activity in zinc-incubated cell lysates, N2a cell lysates were incubated with0,10,50,100μM zinc sulfate for30min, or with10μM zinc sulfate for0,10,30,60min at30°C. At the end of incubation, the lysate were collected for PP2A activity assay. For theanalysis of zinc interaction site, different fragments of PP2Ac (GST-PP2A_(1-50)、PP2AR51-270Rand PP2AR_(271-309)R were expressed and purified, and then incubated with or without100μMzinc. The PP2A activities were detected.For the zinc binding assay, IDA-agarose wasincubated with or without Zn~(2+)PPfor30min and added with GST-PP2AcR(1-50)R,GST-PP2AcR_((51-270))Ror GST-PP2AcR(271-309)Rproteins separately at room temperature for30min. After the incubation, the proteins were washed with different buffers, the elutionswere collected for Western blotting by using antibody against GST.
【Results】The results showed that zinc mimic the inhibitory effect of oadaic acid (OA) onPP2A and prevented tau dephosphorylation in N~2a cell lysates. PP2A activity assay resultindicated that low concentration (10μM) of zinc inhibited PP2A directly. FurtherZn~(2-)PP-IDA-Agarose Affinity Binding Assay showed that zinc bound to and inhibitedPP2Ac_((51-270))but not PP2Ac_((1-50))Rand PP2Ac_((271-309))Rsegement directly. 【Conclusion】Zinc inhibits PP2Adirectly through binding to PP2Ac_((51-270))Rin vitro.
引文
[1]Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder,L. I.,1986,"Abnormal phosphorylation of the microtubule-associated protein tau (tau)in Alzheimer cytoskeletal pathology," Proc Natl Acad Sci U S A,83(13), pp.4913-4917.
[2] Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., and Wisniewski,H. M.,1986,"Microtubule-associated protein tau. A component of Alzheimer pairedhelical filaments," J Biol Chem,261(13), pp.6084-6089.
[3] Kosik, K. S., Joachim, C. L., and Selkoe, D. J.,1986,"Microtubule-associated proteintau (tau) is a major antigenic component of paired helical filaments in Alzheimerdisease," Proc Natl Acad Sci U S A,83(11), pp.4044-4048.
[4] Lee, V. M., Balin, B. J., Otvos, L. J., and Trojanowski, J. Q.,1991,"A68: a majorsubunit of paired helical filaments and derivatized forms of normal Tau," Science,251(4994), pp.675-678.
[5] Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida,T., and Imahori, K.,1993,"Glycogen synthase kinase3beta is identical to tau proteinkinase I generating several epitopes of paired helical filaments," Febs Lett,325(3), pp.167-172.
[6] Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., and Et, A.,1994,"Alzheimer'sdisease-like phosphorylation of the microtubule-associated protein tau by glycogensynthase kinase-3in transfected mammalian cells," Curr Biol,4(12), pp.1077-1086.
[7]Pei, J. J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., and Cowburn,R. F.,1999,"Distribution of active glycogen synthase kinase3beta (GSK-3beta) inbrains staged for Alzheimer disease neurofibrillary changes," J Neuropathol ExpNeurol,58(9), pp.1010-1019.
[8] Gong, C. X., Shaikh, S., Wang, J. Z., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K.,1995,"Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimerdisease brain," J Neurochem,65(2), pp.732-738.
[9] Gong, C. X., Singh, T. J., Grundke-Iqbal, I., and Iqbal, K.,1993,"Phosphoproteinphosphatase activities in Alzheimer disease brain," J Neurochem,61(3), pp.921-927.
[10] Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C. X.,2005,"Contributions of proteinphosphatases PP1, PP2A, PP2B and PP5to the regulation of tau phosphorylation," EurJ Neurosci,22(8), pp.1942-1950.
[11] Wang, J. Z., Gong, C. X., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K.,1995,"Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2Aand-2B," J Biol Chem,270(9), pp.4854-4860.
[12] Chen, S., Li, B., Grundke-Iqbal, I., and Iqbal, K.,2008,"I1PP2A affects tauphosphorylation via association with the catalytic subunit of protein phosphatase2A," J Biol Chem,283(16), pp.10513-10521.
[13] Janssens, V., and Goris, J.,2001,"Protein phosphatase2A: a highly regulated familyof serine/threonine phosphatases implicated in cell growth and signalling," Biochem J,353(Pt3), pp.417-439.
[14] Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., and White,C. R.,2004,"Altered expression levels of the protein phosphatase2A ABalphaCenzyme are associated with Alzheimer disease pathology," J Neuropathol Exp Neurol,63(4), pp.287-301.
[15] Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., and Mumby, M. C.,1996,"Regulation of the phosphorylation state and microtubule-binding activity of Tau byprotein phosphatase2A," Neuron,17(6), pp.1201-1207.
[16] Tanimukai, H., Grundke-Iqbal, I., and Iqbal, K.,2005,"Up-regulation of inhibitors ofprotein phosphatase-2A in Alzheimer's disease," Am J Pathol,166(6), pp.1761-1771.
[17] Chen, J., Parsons, S., and Brautigan, D. L.,1994,"Tyrosine phosphorylation of proteinphosphatase2A in response to growth stimulation and v-src transformation offibroblasts," J Biol Chem,269(11), pp.7957-7962.
[18] Chen, J., Martin, B. L., and Brautigan, D. L.,1992,"Regulation of proteinserine-threonine phosphatase type-2A by tyrosine phosphorylation," Science,257(5074), pp.1261-1264.
[19] Liu, R., Zhou, X. W., Tanila, H., Bjorkdahl, C., Wang, J. Z., Guan, Z. Z., Cao, Y.,Gustafsson, J. A., Winblad, B., and Pei, J. J.,2008,"Phosphorylated PP2A (tyrosine307) is associated with Alzheimer neurofibrillary pathology," J Cell Mol Med,12(1),pp.241-257.
[20] Deibel, M. A., Ehmann, W. D., and Markesbery, W. R.,1996,"Copper, iron, and zincimbalances in severely degenerated brain regions in Alzheimer's disease: possiblerelation to oxidative stress," J Neurol Sci,143(1-2), pp.137-142.
[21] Religa, D., Strozyk, D., Cherny, R. A., Volitakis, I., Haroutunian, V., Winblad, B.,Naslund, J., and Bush, A. I.,2006,"Elevated cortical zinc in Alzheimer disease,"Neurology,67(1), pp.69-75.
[22] Bush, A. I., Pettingell, W. H., Multhaup, G., D, P. M., Vonsattel, J. P., Gusella, J. F.,Beyreuther, K., Masters, C. L., and Tanzi, R. E.,1994,"Rapid induction of AlzheimerA beta amyloid formation by zinc," Science,265(5177), pp.1464-1467.
[23] Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C.A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y., Huang, X., Goldstein, L. E.,Moir, R. D., Lim, J. T., Beyreuther, K., Zheng, H., Tanzi, R. E., Masters, C. L., andBush, A. I.,2001,"Treatment with a copper-zinc chelator markedly and rapidlyinhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice," Neuron,30(3), pp.665-676.
[24] Esler, W. P., Stimson, E. R., Jennings, J. M., Ghilardi, J. R., Mantyh, P. W., andMaggio, J. E.,1996,"Zinc-induced aggregation of human and rat beta-amyloidpeptides in vitro," J Neurochem,66(2), pp.723-732.
[25] Boom, A., Authelet, M., Dedecker, R., Frederick, C., Van Heurck, R., Daubie, V.,Leroy, K., Pochet, R., and Brion, J. P.,2009,"Bimodal modulation of tau proteinphosphorylation and conformation by extracellular Zn2+in human-tau transfectedcells," Biochim Biophys Acta,1793(6), pp.1058-1067.
[26] Samet, J. M., Dewar, B. J., Wu, W., and Graves, L. M.,2003,"Mechanisms ofZn(2+)-induced signal initiation through the epidermal growth factor receptor,"Toxicol Appl Pharmacol,191(1), pp.86-93.
[27] Lee, S., Chanoit, G., McIntosh, R., Zvara, D. A., and Xu, Z.,2009,"Molecularmechanism underlying Akt activation in zinc-induced cardioprotection," Am J PhysiolHeart Circ Physiol,297(2), pp. H569-H575.
[28] Sun, X. Y., Wei, Y. P., Xiong, Y., Wang, X. C., Xie, A. J., Wang, X. L., Yang, Y.,Wang, Q., Lu, Y. M., Liu, R., and Wang, J. Z.,2012,"Synaptic released zinc promotestau hyperphosphorylation by inhibition of protein phosphatase2A (PP2A)," J BiolChem,287(14), pp.11174-11182.
[29] Andorfer, C., Kress, Y., Espinoza, M., de Silva, R., Tucker, K. L., Barde, Y. A., Duff,K., and Davies, P.,2003,"Hyperphosphorylation and aggregation of tau in miceexpressing normal human tau isoforms," J Neurochem,86(3), pp.582-590.
[30] Kroon, J. P., and Riley, A. L.,1986,"A microcomputer-based system for stereotaxiccoordinates in the rat brain," Physiol Behav,38(4), pp.593-596.
[31] Donella, D. A., Mac, G. C., Cohen, P., Marchiori, F., Meyer, H. E., and Pinna, L. A.,1990,"An investigation of the substrate specificity of protein phosphatase2C usingsynthetic peptide substrates; comparison with protein phosphatase2A," BiochimBiophys Acta,1051(2), pp.199-202.
[32] Liu, Y. H., Wei, W., Yin, J., Liu, G. P., Wang, Q., Cao, F. Y., and Wang, J. Z.,2009,"Proteasome inhibition increases tau accumulation independent of phosphorylation,"Neurobiol Aging,30(12), pp.1949-1961.
[33] White, A. R., Du T, Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E.,Hoke, D. E., Holsinger, R. M., Evin, G., Cherny, R. A., Hill, A. F., Barnham, K. J., Li,Q. X., Bush, A. I., and Masters, C. L.,2006,"Degradation of the Alzheimer diseaseamyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity," JBiol Chem,281(26), pp.17670-17680.
[34] Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J.,Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., Masters, C. L., Bush, A.I., Barnham, K. J., and White, A. R.,2011,"The Alzheimer's therapeutic PBT2promotes amyloid-beta degradation and GSK3phosphorylation via a metal chaperoneactivity," J Neurochem,119(1), pp.220-230.
[35] Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., and Hannun, Y. A.,1993,"Ceramide activates heterotrimeric protein phosphatase2A," J Biol Chem,268(21), pp.15523-15530.
[36] Findik, D., and Presek, P.,1988,"Zn2+enhances protein tyrosine kinase activity ofhuman platelet membranes," Febs Lett,235(1-2), pp.51-56.
[37] Pandey, N. R., Vardatsikos, G., Mehdi, M. Z., and Srivastava, A. K.,2010,"Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2and PKB phosphorylation," J Biol Inorg Chem,15(3), pp.399-407.
[38] Wu, W., Graves, L. M., Gill, G. N., Parsons, S. J., and Samet, J. M.,2002,"Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine845is required for zinc-induced Ras activation," J Biol Chem,277(27), pp.24252-24257.
[39] Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M.,Volitakis, I., Liu, X., Smith, J. P., Perez, K., Laughton, K., Li, Q. X., Charman, S. A.,Nicolazzo, J. A., Wilkins, S., Deleva, K., Lynch, T., Kok, G., Ritchie, C. W., Tanzi, R.E., Cappai, R., Masters, C. L., Barnham, K. J., and Bush, A. I.,2008,"Rapidrestoration of cognition in Alzheimer's transgenic mice with8-hydroxy quinolineanalogs is associated with decreased interstitial Abeta," Neuron,59(1), pp.43-55.
[40] Crawford, I. L., and Connor, J. D.,1972,"Zinc in maturing rat brain: hippocampalconcentration and localization," J Neurochem,19(6), pp.1451-1458.
[41] Hu, K. H., and Friede, R. L.,1968,"Topographic determination of zinc in human brainby atomic absorption spectrophotometry," J Neurochem,15(7), pp.677-685.
[42] Ding, H., Matthews, T. A., and Johnson, G. V.,2006,"Site-specific phosphorylationand caspase cleavage differentially impact tau-microtubule interactions and tauaggregation," J Biol Chem,281(28), pp.19107-19114.
[43] Rankin, C. A., Sun, Q., and Gamblin, T. C.,2005,"Pseudo-phosphorylation of tau atSer202and Thr205affects tau filament formation," Brain Res Mol Brain Res,138(1),pp.84-93.
[44] Janssens, V., and Goris, J.,2001,"Protein phosphatase2A: a highly regulated familyof serine/threonine phosphatases implicated in cell growth and signalling," Biochem J,353(Pt3), pp.417-439.
[45] Mumby, M.,2007,"PP2A: unveiling a reluctant tumor suppressor," Cell,130(1), pp.21-24.
[46] Kim, I., Park, E. J., Seo, J., Ko, S. J., Lee, J., and Kim, C. H.,2011,"Zinc stimulatestau S214phosphorylation by the activation of Raf/mitogen-activated proteinkinase-kinase/extracellular signal-regulated kinase pathway," Neuroreport,22(16), pp.839-844.
[47] An, W. L., Bjorkdahl, C., Liu, R., Cowburn, R. F., Winblad, B., and Pei, J. J.,2005,"Mechanism of zinc-induced phosphorylation of p70S6kinase and glycogen synthasekinase3beta in SH-SY5Y neuroblastoma cells," J Neurochem,92(5), pp.1104-1115.
[48] Ogris, E., Gibson, D. M., and Pallas, D. C.,1997,"Protein phosphatase2A subunitassembly: the catalytic subunit carboxy terminus is important for binding cellular Bsubunit but not polyomavirus middle tumor antigen," Oncogene,15(8), pp.911-917.
[49] Baharians, Z., and Schonthal, A. H.,1998,"Autoregulation of protein phosphatasetype2A expression," J Biol Chem,273(30), pp.19019-19024.
[50] Green, D. D., Yang, S. I., and Mumby, M. C.,1987,"Molecular cloning and sequenceanalysis of the catalytic subunit of bovine type2A protein phosphatase," Proc NatlAcad Sci U S A,84(14), pp.4880-4884.
[51] Findik, D., and Presek, P.,1988,"Zn2+enhances protein tyrosine kinase activity ofhuman platelet membranes," Febs Lett,235(1-2), pp.51-56.
[52] Manzerra, P., Behrens, M. M., Canzoniero, L. M., Wang, X. Q., Heidinger, V.,Ichinose, T., Yu, S. P., and Choi, D. W.,2001,"Zinc induces a Src familykinase-mediated up-regulation of NMDA receptor activity and excitotoxicity," ProcNatl Acad Sci U S A,98(20), pp.11055-11061.
[53] Kim, T. Y., Hwang, J. J., Yun, S. H., Jung, M. W., and Koh, J. Y.,2002,"Augmentation by zinc of NMDA receptor-mediated synaptic responses in CA1of rathippocampal slices: mediation by Src family tyrosine kinases," Synapse,46(2), pp.49-56.
[54] Liao, S. L., Ou, Y. C., Lin, S. Y., Kao, T. K., Pan, H. C., Chang, C. Y., Lai, C. Y., Lu,H. C., Wang, W. Y., and Chen, C. J.,2011,"Signaling cascades mediate astrocytedeath induced by zinc," Toxicol Lett,204(2-3), pp.108-117.
[1].Gong, C.X., et al., Phosphatase activity toward abnormally phosphorylated tau:decrease in Alzheimer disease brain. J Neurochem,1995.65(2): p.732-8.
[2].Liu, F., et al., Contributions of protein phosphatases PP1, PP2A, PP2B and PP5to theregulation of tau phosphorylation. Eur J Neurosci,2005.22(8): p.1942-50.
[3].Wang, J.Z., et al., Dephosphorylation of Alzheimer paired helical filaments by proteinphosphatase-2A and-2B. J Biol Chem,1995.270(9): p.4854-60.
[4].Cai, L., et al., A metal-dependent form of protein phosphatase2A. Biochem BiophysRes Commun,1995.208(1): p.274-9.
[5].Galadari, S., A. Hago and M. Patel, Effects of cations on ceramide-activated proteinphosphatase2A. Exp Mol Med,2001.33(4): p.240-4.
[6].Goldberg, J., et al., Three-dimensional structure of the catalytic subunit of proteinserine/threonine phosphatase-1. Nature,1995.376(6543): p.745-53.
[7].Sun, X.Y., et al., Synaptic released zinc promotes tau hyperphosphorylation byinhibition of protein phosphatase2A (PP2A). J Biol Chem,2012.287(14): p.11174-82.
[8].Xiong, Y., et al., Zinc induces protein phosphatase2A inactivation and tauhyperphosphorylation through Src dependent PP2A (tyrosine307) phosphorylation.Neurobiol Aging,2013.34(3): p.745-56.
[9].Haase, H. and W. Maret, Intracellular zinc fluctuations modulate protein tyrosinephosphatase activity in insulin/insulin-like growth factor-1signaling. Exp Cell Res,2003.291(2): p.289-98.
[10].Yuan, H., et al., The serine protease plasmin cleaves the amino-terminal domain of theNR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors. J BiolChem,2009.284(19): p.12862-73.
[11].Goldberg, J., et al., Three-dimensional structure of the catalytic subunit of proteinserine/threonine phosphatase-1. Nature,1995.376(6543): p.745-53.
[12].Fellner, T., et al., A novel and essential mechanism determining specificity andactivity of protein phosphatase2A (PP2A) in vivo. Genes Dev,2003.17(17): p.2138-50.
[13].Janssens, V. and J. Goris, Protein phosphatase2A: a highly regulated family ofserine/threonine phosphatases implicated in cell growth and signalling. Biochem J,2001.353(Pt3): p.417-39.
[14].Goldberg, Y., Protein phosphatase2A: who shall regulate the regulator? BiochemPharmacol,1999.57(4): p.321-8.
[15].Li, M., A. Makkinje and Z. Damuni, The myeloid leukemia-associated protein SET isa potent inhibitor of protein phosphatase2A. J Biol Chem,1996.271(19): p.11059-62.
[16].Li, M., H. Guo and Z. Damuni, Purification and characterization of two potentheat-stable protein inhibitors of protein phosphatase2A from bovine kidney.Biochemistry,1995.34(6): p.1988-96.
[17].Cohen, P.T., Novel protein serine/threonine phosphatases: variety is the spice of life.Trends Biochem Sci,1997.22(7): p.245-51.
[18].Liu, R., et al., Phosphorylated PP2A (tyrosine307) is associated with Alzheimerneurofibrillary pathology. J Cell Mol Med,2008.12(1): p.241-57.
[19].King, M.M. and C.Y. Huang, The calmodulin-dependent activation and deactivationof the phosphoprotein phosphatase, calcineurin, and the effect of nucleotides,pyrophosphate, and divalent metal ions. Identification of calcineurin as a Zn and Femetalloenzyme. J Biol Chem,1984.259(14): p.8847-56.
[20].Zhuo, S. and J.E. Dixon, Effects of sulfhydryl regents on the activity of lambdaSer/Thr phosphoprotein phosphatase and inhibition of the enzyme by zinc ion. ProteinEng,1997.10(12): p.1445-52.
[21].Wang, J.Z., I. Grundke-Iqbal and K. Iqbal, Restoration of biological activity ofAlzheimer abnormally phosphorylated tau by dephosphorylation with proteinphosphatase-2A,-2B and-1. Brain Res Mol Brain Res,1996.38(2): p.200-8.
[22].Fernandez, J.J., et al., Okadaic acid, useful tool for studying cellular processes. CurrMed Chem,2002.9(2): p.229-62.
[23].Goldberg, J., et al., Three-dimensional structure of the catalytic subunit of proteinserine/threonine phosphatase-1. Nature,1995.376(6543): p.745-53.
[1] Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. BrainRes1982;239(1):57-69.
[2] Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW. The role of zinc in selectiveneuronal death after transient global cerebral ischemia. Science1996;272(5264):1013-6.
[3] Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S.Calpain-dependent proteolytic cleavage of the p35cyclin-dependent kinase5activatorto p25. J Biol Chem2000;275(22):17166-72.
[4] Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity inducescleavage of p35to p25by calpain. Nature2000;405(6784):360-4.
[5] Nath R, Davis M, Probert AW, Kupina NC, Ren X, Schielke GP, Wang KK.Processing of cdk5activator p35to its truncated form (p25) by calpain in acutelyinjured neuronal cells. Biochem Biophys Res Commun2000;274(1):16-21.
[6] Wang J, Liu S, Fu Y, Wang JH, Lu Y. Cdk5activation induces hippocampal CA1celldeath by directly phosphorylating NMDA receptors. Nat Neurosci2003;6(10):1039-47.
[7] Weishaupt JH, Kussmaul L, Grotsch P, Heckel A, Rohde G, Romig H, Bahr M,Gillardon F. Inhibition of CDK5is protective in necrotic and apoptotic paradigms ofneuronal cell death and prevents mitochondrial dysfunction. Mol Cell Neurosci2003;24(2):489-502.
[1] Janssens, V., and Goris, J.,2001,"Protein phosphatase2A: a highly regulated familyof serine/threonine phosphatases implicated in cell growth and signalling," Biochem J,353(Pt3), pp.417-439.
[2] Goldberg, Y.,1999,"Protein phosphatase2A: who shall regulate the regulator?"Biochem Pharmacol,57(4), pp.321-328.
[3] Van Hoof, C., and Goris, J.,2003,"Phosphatases in apoptosis: to be or not to be,PP2A is in the heart of the question," Biochim Biophys Acta,1640(2-3), pp.97-104.
[4] Flegg, C. P., Sharma, M., Medina-Palazon, C., Jamieson, C., Galea, M., Brocardo, M.G., Mills, K., and Henderson, B. R.,2010,"Nuclear export and centrosome targetingof the protein phosphatase2A subunit B56alpha: role of B56alpha in nuclear export ofthe catalytic subunit," J Biol Chem,285(24), pp.18144-18154.
[5] Agostinis, P., Derua, R., Sarno, S., Goris, J., and Merlevede, W.,1992,"Specificity ofthe polycation-stimulated (type-2A) and ATP,Mg-dependent (type-1) proteinphosphatases toward substrates phosphorylated by P34cdc2kinase," Eur J Biochem,205(1), pp.241-248.
[6] Mumby, M. C., Russell, K. L., Garrard, L. J., and Green, D. D.,1987,"Cardiaccontractile protein phosphatases. Purification of two enzyme forms and theircharacterization with subunit-specific antibodies," J Biol Chem,262(13), pp.6257-6265.
[7] Imaoka, T., Imazu, M., Usui, H., Kinohara, N., and Takeda, M.,1983,"Resolution andreassociation of three distinct components from pig heart phosphoproteinphosphatase," J Biol Chem,258(3), pp.1526-1535.
[8] Turowski, P., Myles, T., Hemmings, B. A., Fernandez, A., and Lamb, N. J.,1999,"Vimentin dephosphorylation by protein phosphatase2A is modulated by the targetingsubunit B55," Mol Biol Cell,10(6), pp.1997-2015.
[9] Mayer-Jaekel, R. E., Ohkura, H., Ferrigno, P., Andjelkovic, N., Shiomi, K., Uemura,T., Glover, D. M., and Hemmings, B. A.,1994,"Drosophila mutants in the55kDaregulatory subunit of protein phosphatase2A show strongly reduced ability todephosphorylate substrates of p34cdc2," J Cell Sci,107(Pt9), pp.2609-2616.
[10] Chen, J., Martin, B. L., and Brautigan, D. L.,1992,"Regulation of proteinserine-threonine phosphatase type-2A by tyrosine phosphorylation," Science,257(5074), pp.1261-1264.
[11] Takai, A., and Mieskes, G.,1991,"Inhibitory effect of okadaic acid on thep-nitrophenyl phosphate phosphatase activity of protein phosphatases," Biochem J,275(Pt1), pp.233-239.
[12] Xiong, Y., Jing, X. P., Zhou, X. W., Wang, X. L., Yang, Y., Sun, X. Y., Qiu, M., Cao,F. Y., Lu, Y. M., Liu, R., and Wang, J. Z.,2013,"Zinc induces protein phosphatase2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine307) phosphorylation," Neurobiol Aging,34(3), pp.745-756.
[13] Sun, X. Y., Wei, Y. P., Xiong, Y., Wang, X. C., Xie, A. J., Wang, X. L., Yang, Y.,Wang, Q., Lu, Y. M., Wang, J. Z., and Liu, R.,2012,"Synaptic released zinc promotestau hyperphosphorylation by inhibition of PP2A," J Biol Chem.
[14] Qi, Z., Yang, W., Liu, Y., Cui, T., Gao, H., Duan, C., Lu, L., Zhao, C., Zhao, H., andYang, H.,2011,"Loss of PINK1function decreases PP2A activity and promotesautophagy in dopaminergic cells and a murine model," Neurochem Int,59(5), pp.572-581.
[15] Lee, J., and Stock, J.,1993,"Protein phosphatase2A catalytic subunit ismethyl-esterified at its carboxyl terminus by a novel methyltransferase," J Biol Chem,268(26), pp.19192-19195.
[16] Xie, H., and Clarke, S.,1994,"Protein phosphatase2A is reversibly modified bymethyl esterification at its C-terminal leucine residue in bovine brain," J Biol Chem,269(3), pp.1981-1984.
[17] De Baere, I., Derua, R., Janssens, V., Van Hoof, C., Waelkens, E., Merlevede, W., andGoris, J.,1999,"Purification of porcine brain protein phosphatase2A leucine carboxylmethyltransferase and cloning of the human homologue," Biochemistry-Us,38(50), pp.16539-16547.
[18] Lee, J., and Stock, J.,1993,"Protein phosphatase2A catalytic subunit ismethyl-esterified at its carboxyl terminus by a novel methyltransferase," J Biol Chem,268(26), pp.19192-19195.
[19] Sontag, J. M., Nunbhakdi-Craig, V., Mitterhuber, M., Ogris, E., and Sontag, E.,2010,"Regulation of protein phosphatase2A methylation by LCMT1and PME-1plays acritical role in differentiation of neuroblastoma cells," J Neurochem,115(6), pp.1455-1465.
[20] Lee, J., Chen, Y., Tolstykh, T., and Stock, J.,1996,"A specific protein carboxylmethylesterase that demethylates phosphoprotein phosphatase2A in bovine brain,"Proc Natl Acad Sci U S A,93(12), pp.6043-6047.
[21] Wu, J., Tolstykh, T., Lee, J., Boyd, K., Stock, J. B., and Broach, J. R.,2000,"Carboxyl methylation of the phosphoprotein phosphatase2A catalytic subunitpromotes its functional association with regulatory subunits in vivo," Embo J,19(21),pp.5672-5681.
[22] Xu, Y., Xing, Y., Chen, Y., Chao, Y., Lin, Z., Fan, E., Yu, J. W., Strack, S., Jeffrey, P.D., and Shi, Y.,2006,"Structure of the protein phosphatase2A holoenzyme," Cell,127(6), pp.1239-1251.
[23] Xu, Y., Chen, Y., Zhang, P., Jeffrey, P. D., and Shi, Y.,2008,"Structure of a proteinphosphatase2A holoenzyme: insights into B55-mediated Tau dephosphorylation,"Mol Cell,31(6), pp.873-885.
[24] Longin, S., Zwaenepoel, K., Martens, E., Louis, J. V., Rondelez, E., Goris, J., andJanssens, V.,2008,"Spatial control of protein phosphatase2A (de)methylation," ExpCell Res,314(1), pp.68-81.
[25] Longin, S., Zwaenepoel, K., Louis, J. V., Dilworth, S., Goris, J., and Janssens, V.,2007,"Selection of protein phosphatase2A regulatory subunits is mediated by the Cterminus of the catalytic Subunit," J Biol Chem,282(37), pp.26971-26980.
[26] Shi, Y.,2009,"Serine/threonine phosphatases: mechanism through structure," Cell,139(3), pp.468-484.
[27] Xing, Y., Li, Z., Chen, Y., Stock, J. B., Jeffrey, P. D., and Shi, Y.,2008,"Structuralmechanism of demethylation and inactivation of protein phosphatase2A," Cell,133(1),pp.154-163.
[28] Hombauer, H., Weismann, D., Mudrak, I., Stanzel, C., Fellner, T., Lackner, D. H., andOgris, E.,2007,"Generation of active protein phosphatase2A is coupled toholoenzyme assembly," PLoS Biol,5(6), p. e155.
[29] Li, M., Guo, H., and Damuni, Z.,1995,"Purification and characterization of twopotent heat-stable protein inhibitors of protein phosphatase2A from bovine kidney,"Biochemistry-Us,34(6), pp.1988-1996.
[30] Li, M., Makkinje, A., and Damuni, Z.,1996,"The myeloid leukemia-associatedprotein SET is a potent inhibitor of protein phosphatase2A," J Biol Chem,271(19), pp.11059-11062.
[31] Guo, H., and Damuni, Z.,1993,"Autophosphorylation-activated protein kinasephosphorylates and inactivates protein phosphatase2A," Proc Natl Acad Sci U S A,90(6), pp.2500-2504.
[32] Junttila, M. R., Puustinen, P., Niemela, M., Ahola, R., Arnold, H., Bottzauw, T.,Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., Lu, S. L., Lin, S., Chan, E. K., Wang, X.J., Grenman, R., Kast, J., Kallunki, T., Sears, R., Kahari, V. M., and Westermarck, J.,2007,"CIP2A inhibits PP2A in human malignancies," Cell,130(1), pp.51-62.
[33] Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W.C., Stukenberg, P. T., Shenolikar, S., Uchida, T., Counter, C. M., Nevins, J. R., Means,A. R., and Sears, R.,2004,"A signalling pathway controlling c-Myc degradation thatimpacts oncogenic transformation of human cells," Nat Cell Biol,6(4), pp.308-318.
[34] Arnold, H. K., and Sears, R. C.,2006,"Protein phosphatase2A regulatory subunitB56alpha associates with c-myc and negatively regulates c-myc accumulation," MolCell Biol,26(7), pp.2832-2844.
[35] Chao, Y., Xing, Y., Chen, Y., Xu, Y., Lin, Z., Li, Z., Jeffrey, P. D., Stock, J. B., andShi, Y.,2006,"Structure and mechanism of the phosphotyrosyl phosphataseactivator," Mol Cell,23(4), pp.535-546.
[36] Schild, A., Ittner, L. M., and Gotz, J.,2006,"Altered phosphorylation of cytoskeletalproteins in mutant protein phosphatase2A transgenic mice," Biochem Biophys ResCommun,343(4), pp.1171-1178.
[37] Holm, L., and Sander, C.,1993,"Protein structure comparison by alignment ofdistance matrices," J Mol Biol,233(1), pp.123-138.
[38] Fellner, T., Lackner, D. H., Hombauer, H., Piribauer, P., Mudrak, I., Zaragoza, K.,Juno, C., and Ogris, E.,2003,"A novel and essential mechanism determiningspecificity and activity of protein phosphatase2A (PP2A) in vivo," Genes Dev,17(17),pp.2138-2150.
[39] Luo, Y., Nie, Y. J., Shi, H. R., Ni, Z. F., Wang, Q., Wang, J. Z., and Liu, G. P.,2013,"PTPA activates protein phosphatase-2A through reducing its phosphorylation attyrosine-307with upregulation of protein tyrosine phosphatase1B," Biochim BiophysActa,1833(5), pp.1235-1243.
[40] Cai, L., Chu, Y., Wilson, S. E., and Schlender, K. K.,1995,"A metal-dependent formof protein phosphatase2A," Biochem Biophys Res Commun,208(1), pp.274-279.
[41] Yu, J. S.,1998,"Activation of protein phosphatase2A by the Fe2+/ascorbate system,"J Biochem,124(1), pp.225-230.
[42] Galadari, S., Hago, A., and Patel, M.,2001,"Effects of cations on ceramide-activatedprotein phosphatase2A," Exp Mol Med,33(4), pp.240-244.
[43] Wozniak, E., Oldziej, S., and Ciarkowski, J.,2000,"Molecular modeling of thecatalytic domain of serine/threonine phosphatase-1with the Zn2+and Mn2+di-nuclear ion centers in the active site," Comput Chem,24(3-4), pp.381-390.
[44] Wirt, S. E., and Sage, J.,2010,"p107in the public eye: an Rb understudy and more,"Cell Div,5, p.9.
[45] Garriga, J., Jayaraman, A. L., Limon, A., Jayadeva, G., Sotillo, E., Truongcao, M.,Patsialou, A., Wadzinski, B. E., and Grana, X.,2004,"A dynamic equilibriumbetween CDKs and PP2A modulates phosphorylation of pRB, p107and p130," CellCycle,3(10), pp.1320-1330.
[46] Kurimchak, A., and Grana, X.,2012,"PP2A holoenzymes negatively and positivelyregulate cell cycle progression by dephosphorylating pocket proteins and multipleCDK substrates," Gene,499(1), pp.1-7.
[47] Zolnierowicz, S.,2000,"Type2A protein phosphatase, the complex regulator ofnumerous signaling pathways," Biochem Pharmacol,60(8), pp.1225-1235.
[48] Gould, K. L., Moreno, S., Owen, D. J., Sazer, S., and Nurse, P.,1991,"Phosphorylation at Thr167is required for Schizosaccharomyces pombe p34cdc2function," Embo J,10(11), pp.3297-3309.
[49] Kinoshita, N., Yamano, H., Niwa, H., Yoshida, T., and Yanagida, M.,1993,"Negativeregulation of mitosis by the fission yeast protein phosphatase ppa2," Genes Dev,7(6),pp.1059-1071.
[50]Krasinska, L., Domingo-Sananes, M. R., Kapuy, O., Parisis, N., Harker, B., Moorhead,G., Rossignol, M., Novak, B., and Fisher, D.,2011,"Protein phosphatase2A controlsthe order and dynamics of cell-cycle transitions," Mol Cell,44(3), pp.437-450.
[51] Lindqvist, A., Rodriguez-Bravo, V., and Medema, R. H.,2009,"The decision to entermitosis: feedback and redundancy in the mitotic entry network," J Cell Biol,185(2),pp.193-202.
[52] Clarke, P. R., Hoffmann, I., Draetta, G., and Karsenti, E.,1993,"Dephosphorylation ofcdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle inXenopus egg extracts," Mol Biol Cell,4(4), pp.397-411.
[53] Blagosklonny, M. V.,2001,"Unwinding the loop of Bcl-2phosphorylation,"Leukemia,15(6), pp.869-874.
[54] Deng, X., Ruvolo, P., Carr, B., and May, W. J.,2000,"Survival function of ERK1/2asIL-3-activated, staurosporine-resistant Bcl2kinases," Proc Natl Acad Sci U S A,97(4),pp.1578-1583.
[55] Ruvolo, P. P., Deng, X., Carr, B. K., and May, W. S.,1998,"A functional role formitochondrial protein kinase Calpha in Bcl2phosphorylation and suppression ofapoptosis," J Biol Chem,273(39), pp.25436-25442.
[56] Muscarella, D. E., and Bloom, S. E.,2008,"The contribution of c-Jun N-terminalkinase activation and subsequent Bcl-2phosphorylation to apoptosis induction inhuman B-cells is dependent on the mode of action of specific stresses," Toxicol ApplPharmacol,228(1), pp.93-104.
[57] Deng, X., Ito, T., Carr, B., Mumby, M., and May, W. J.,1998,"Reversiblephosphorylation of Bcl2following interleukin3or bryostatin1is mediated by directinteraction with protein phosphatase2A," J Biol Chem,273(51), pp.34157-34163.
[58] Ruvolo, P. P., Deng, X., Ito, T., Carr, B. K., and May, W. S.,1999,"Ceramide inducesBcl2dephosphorylation via a mechanism involving mitochondrial PP2A," J BiolChem,274(29), pp.20296-20300.
[59] Van Hoof, C., and Goris, J.,2003,"Phosphatases in apoptosis: to be or not to be,PP2A is in the heart of the question," Biochim Biophys Acta,1640(2-3), pp.97-104.
[60] Lv, X., Wan, J., Yang, J., Cheng, H., Li, Y., Ao, Y., and Peng, R.,2008,"CytochromeP450omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activationof ERK1/2signaling in rat myocardial ischemia-reperfusion," Eur J Pharmacol,596(1-3), pp.118-126.
[61] Chang, H., Lin, H., Yi, L., Zhu, J., Zhou, Y., Mi, M., and Zhang, Q.,2010,"3,6-Dihydroxyflavone induces apoptosis in leukemia HL-60cell via reactive oxygenspecies-mediated p38MAPK/JNK pathway," Eur J Pharmacol,648(1-3), pp.31-38.
[62] Liu, G. P., Wei, W., Zhou, X., Zhang, Y., Shi, H. H., Yin, J., Yao, X. Q., Peng, C. X.,Hu, J., Wang, Q., Li, H. L., and Wang, J. Z.,2012,"I(2)(PP2A) regulates p53and Aktcorrelatively and leads the neurons to abort apoptosis," Neurobiol Aging,33(2), pp.254-264.
[63] Klionsky, D. J.,2008,"Autophagy revisited: a conversation with Christian de Duve,"Autophagy,4(6), pp.740-743.
[64] Mizushima, N., and Komatsu, M.,2011,"Autophagy: renovation of cells and tissues,"Cell,147(4), pp.728-741.
[65] Chen, Y., and Klionsky, D. J.,2011,"The regulation of autophagy-unansweredquestions," J Cell Sci,124(Pt2), pp.161-170.
[66] Mizushima, N., Yoshimori, T., and Ohsumi, Y.,2011,"The role of Atg proteins inautophagosome formation," Annu Rev Cell Dev Biol,27, pp.107-132.
[67] Nakatogawa, H., Suzuki, K., Kamada, Y., and Ohsumi, Y.,2009,"Dynamics anddiversity in autophagy mechanisms: lessons from yeast," Nat Rev Mol Cell Biol,10(7),pp.458-467.
[68] Holen, I., Gordon, P. B., and Seglen, P. O.,1993,"Inhibition of hepatocytic autophagyby okadaic acid and other protein phosphatase inhibitors," Eur J Biochem,215(1), pp.113-122.
[69] Zaman, S., Lippman, S. I., Zhao, X., and Broach, J. R.,2008,"How Saccharomycesresponds to nutrients," Annu Rev Genet,42, pp.27-81.
[70] Zabrocki, P., Van Hoof, C., Goris, J., Thevelein, J. M., Winderickx, J., and Wera, S.,2002,"Protein phosphatase2A on track for nutrient-induced signalling in yeast," MolMicrobiol,43(4), pp.835-842.
[71] Maiuri, M. C., Tasdemir, E., Criollo, A., Morselli, E., Vicencio, J. M., Carnuccio, R.,and Kroemer, G.,2009,"Control of autophagy by oncogenes and tumor suppressorgenes," Cell Death Differ,16(1), pp.87-93.
[72] Banreti, A., Lukacsovich, T., Csikos, G., Erdelyi, M., and Sass, M.,2012,"PP2Aregulates autophagy in two alternative ways in Drosophila," Autophagy,8(4), pp.623-636.
[73] Ogura, K., Okada, T., Mitani, S., Gengyo-Ando, K., Baillie, D. L., Kohara, Y., andGoshima, Y.,2010,"Protein phosphatase2A cooperates with the autophagy-relatedkinase UNC-51to regulate axon guidance in Caenorhabditis elegans," Development,137(10), pp.1657-1667.
[74] He, C., and Klionsky, D. J.,2009,"Regulation mechanisms and signaling pathways ofautophagy," Annu Rev Genet,43, pp.67-93.
[75] Potter, C. J., Pedraza, L. G., and Xu, T.,2002,"Akt regulates growth by directlyphosphorylating Tsc2," Nat Cell Biol,4(9), pp.658-665.
[76] Vereshchagina, N., Ramel, M. C., Bitoun, E., and Wilson, C.,2008,"The proteinphosphatase PP2A-B' subunit Widerborst is a negative regulator of cytoplasmicactivated Akt and lipid metabolism in Drosophila," J Cell Sci,121(Pt20), pp.3383-3392.
[77] Potter, C. J., Huang, H., and Xu, T.,2001,"Drosophila Tsc1functions with Tsc2toantagonize insulin signaling in regulating cell growth, cell proliferation, and organsize," Cell,105(3), pp.357-368.
[2] Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., and Wisniewski,H. M.,1986,"Microtubule-associated protein tau. A component of Alzheimer pairedhelical filaments," J Biol Chem,261(13), pp.6084-6089.
[3] Kosik, K. S., Joachim, C. L., and Selkoe, D. J.,1986,"Microtubule-associated proteintau (tau) is a major antigenic component of paired helical filaments in Alzheimerdisease," Proc Natl Acad Sci U S A,83(11), pp.4044-4048.
[4] Lee, V. M., Balin, B. J., Otvos, L. J., and Trojanowski, J. Q.,1991,"A68: a majorsubunit of paired helical filaments and derivatized forms of normal Tau," Science,251(4994), pp.675-678.
[5] Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida,T., and Imahori, K.,1993,"Glycogen synthase kinase3beta is identical to tau proteinkinase I generating several epitopes of paired helical filaments," Febs Lett,325(3), pp.167-172.
[6] Lovestone, S., Reynolds, C. H., Latimer, D., Davis, D. R., Anderton, B. H., Gallo, J.M., Hanger, D., Mulot, S., Marquardt, B., Stabel, S., and Et, A.,1994,"Alzheimer'sdisease-like phosphorylation of the microtubule-associated protein tau by glycogensynthase kinase-3in transfected mammalian cells," Curr Biol,4(12), pp.1077-1086.
[7]Pei, J. J., Braak, E., Braak, H., Grundke-Iqbal, I., Iqbal, K., Winblad, B., and Cowburn,R. F.,1999,"Distribution of active glycogen synthase kinase3beta (GSK-3beta) inbrains staged for Alzheimer disease neurofibrillary changes," J Neuropathol ExpNeurol,58(9), pp.1010-1019.
[8] Gong, C. X., Shaikh, S., Wang, J. Z., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K.,1995,"Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimerdisease brain," J Neurochem,65(2), pp.732-738.
[9] Gong, C. X., Singh, T. J., Grundke-Iqbal, I., and Iqbal, K.,1993,"Phosphoproteinphosphatase activities in Alzheimer disease brain," J Neurochem,61(3), pp.921-927.
[10] Liu, F., Grundke-Iqbal, I., Iqbal, K., and Gong, C. X.,2005,"Contributions of proteinphosphatases PP1, PP2A, PP2B and PP5to the regulation of tau phosphorylation," EurJ Neurosci,22(8), pp.1942-1950.
[11] Wang, J. Z., Gong, C. X., Zaidi, T., Grundke-Iqbal, I., and Iqbal, K.,1995,"Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2Aand-2B," J Biol Chem,270(9), pp.4854-4860.
[12] Chen, S., Li, B., Grundke-Iqbal, I., and Iqbal, K.,2008,"I1PP2A affects tauphosphorylation via association with the catalytic subunit of protein phosphatase2A," J Biol Chem,283(16), pp.10513-10521.
[13] Janssens, V., and Goris, J.,2001,"Protein phosphatase2A: a highly regulated familyof serine/threonine phosphatases implicated in cell growth and signalling," Biochem J,353(Pt3), pp.417-439.
[14] Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., and White,C. R.,2004,"Altered expression levels of the protein phosphatase2A ABalphaCenzyme are associated with Alzheimer disease pathology," J Neuropathol Exp Neurol,63(4), pp.287-301.
[15] Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., and Mumby, M. C.,1996,"Regulation of the phosphorylation state and microtubule-binding activity of Tau byprotein phosphatase2A," Neuron,17(6), pp.1201-1207.
[16] Tanimukai, H., Grundke-Iqbal, I., and Iqbal, K.,2005,"Up-regulation of inhibitors ofprotein phosphatase-2A in Alzheimer's disease," Am J Pathol,166(6), pp.1761-1771.
[17] Chen, J., Parsons, S., and Brautigan, D. L.,1994,"Tyrosine phosphorylation of proteinphosphatase2A in response to growth stimulation and v-src transformation offibroblasts," J Biol Chem,269(11), pp.7957-7962.
[18] Chen, J., Martin, B. L., and Brautigan, D. L.,1992,"Regulation of proteinserine-threonine phosphatase type-2A by tyrosine phosphorylation," Science,257(5074), pp.1261-1264.
[19] Liu, R., Zhou, X. W., Tanila, H., Bjorkdahl, C., Wang, J. Z., Guan, Z. Z., Cao, Y.,Gustafsson, J. A., Winblad, B., and Pei, J. J.,2008,"Phosphorylated PP2A (tyrosine307) is associated with Alzheimer neurofibrillary pathology," J Cell Mol Med,12(1),pp.241-257.
[20] Deibel, M. A., Ehmann, W. D., and Markesbery, W. R.,1996,"Copper, iron, and zincimbalances in severely degenerated brain regions in Alzheimer's disease: possiblerelation to oxidative stress," J Neurol Sci,143(1-2), pp.137-142.
[21] Religa, D., Strozyk, D., Cherny, R. A., Volitakis, I., Haroutunian, V., Winblad, B.,Naslund, J., and Bush, A. I.,2006,"Elevated cortical zinc in Alzheimer disease,"Neurology,67(1), pp.69-75.
[22] Bush, A. I., Pettingell, W. H., Multhaup, G., D, P. M., Vonsattel, J. P., Gusella, J. F.,Beyreuther, K., Masters, C. L., and Tanzi, R. E.,1994,"Rapid induction of AlzheimerA beta amyloid formation by zinc," Science,265(5177), pp.1464-1467.
[23] Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C.A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y., Huang, X., Goldstein, L. E.,Moir, R. D., Lim, J. T., Beyreuther, K., Zheng, H., Tanzi, R. E., Masters, C. L., andBush, A. I.,2001,"Treatment with a copper-zinc chelator markedly and rapidlyinhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice," Neuron,30(3), pp.665-676.
[24] Esler, W. P., Stimson, E. R., Jennings, J. M., Ghilardi, J. R., Mantyh, P. W., andMaggio, J. E.,1996,"Zinc-induced aggregation of human and rat beta-amyloidpeptides in vitro," J Neurochem,66(2), pp.723-732.
[25] Boom, A., Authelet, M., Dedecker, R., Frederick, C., Van Heurck, R., Daubie, V.,Leroy, K., Pochet, R., and Brion, J. P.,2009,"Bimodal modulation of tau proteinphosphorylation and conformation by extracellular Zn2+in human-tau transfectedcells," Biochim Biophys Acta,1793(6), pp.1058-1067.
[26] Samet, J. M., Dewar, B. J., Wu, W., and Graves, L. M.,2003,"Mechanisms ofZn(2+)-induced signal initiation through the epidermal growth factor receptor,"Toxicol Appl Pharmacol,191(1), pp.86-93.
[27] Lee, S., Chanoit, G., McIntosh, R., Zvara, D. A., and Xu, Z.,2009,"Molecularmechanism underlying Akt activation in zinc-induced cardioprotection," Am J PhysiolHeart Circ Physiol,297(2), pp. H569-H575.
[28] Sun, X. Y., Wei, Y. P., Xiong, Y., Wang, X. C., Xie, A. J., Wang, X. L., Yang, Y.,Wang, Q., Lu, Y. M., Liu, R., and Wang, J. Z.,2012,"Synaptic released zinc promotestau hyperphosphorylation by inhibition of protein phosphatase2A (PP2A)," J BiolChem,287(14), pp.11174-11182.
[29] Andorfer, C., Kress, Y., Espinoza, M., de Silva, R., Tucker, K. L., Barde, Y. A., Duff,K., and Davies, P.,2003,"Hyperphosphorylation and aggregation of tau in miceexpressing normal human tau isoforms," J Neurochem,86(3), pp.582-590.
[30] Kroon, J. P., and Riley, A. L.,1986,"A microcomputer-based system for stereotaxiccoordinates in the rat brain," Physiol Behav,38(4), pp.593-596.
[31] Donella, D. A., Mac, G. C., Cohen, P., Marchiori, F., Meyer, H. E., and Pinna, L. A.,1990,"An investigation of the substrate specificity of protein phosphatase2C usingsynthetic peptide substrates; comparison with protein phosphatase2A," BiochimBiophys Acta,1051(2), pp.199-202.
[32] Liu, Y. H., Wei, W., Yin, J., Liu, G. P., Wang, Q., Cao, F. Y., and Wang, J. Z.,2009,"Proteasome inhibition increases tau accumulation independent of phosphorylation,"Neurobiol Aging,30(12), pp.1949-1961.
[33] White, A. R., Du T, Laughton, K. M., Volitakis, I., Sharples, R. A., Xilinas, M. E.,Hoke, D. E., Holsinger, R. M., Evin, G., Cherny, R. A., Hill, A. F., Barnham, K. J., Li,Q. X., Bush, A. I., and Masters, C. L.,2006,"Degradation of the Alzheimer diseaseamyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity," JBiol Chem,281(26), pp.17670-17680.
[34] Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J.,Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., Masters, C. L., Bush, A.I., Barnham, K. J., and White, A. R.,2011,"The Alzheimer's therapeutic PBT2promotes amyloid-beta degradation and GSK3phosphorylation via a metal chaperoneactivity," J Neurochem,119(1), pp.220-230.
[35] Dobrowsky, R. T., Kamibayashi, C., Mumby, M. C., and Hannun, Y. A.,1993,"Ceramide activates heterotrimeric protein phosphatase2A," J Biol Chem,268(21), pp.15523-15530.
[36] Findik, D., and Presek, P.,1988,"Zn2+enhances protein tyrosine kinase activity ofhuman platelet membranes," Febs Lett,235(1-2), pp.51-56.
[37] Pandey, N. R., Vardatsikos, G., Mehdi, M. Z., and Srivastava, A. K.,2010,"Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2and PKB phosphorylation," J Biol Inorg Chem,15(3), pp.399-407.
[38] Wu, W., Graves, L. M., Gill, G. N., Parsons, S. J., and Samet, J. M.,2002,"Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine845is required for zinc-induced Ras activation," J Biol Chem,277(27), pp.24252-24257.
[39] Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M.,Volitakis, I., Liu, X., Smith, J. P., Perez, K., Laughton, K., Li, Q. X., Charman, S. A.,Nicolazzo, J. A., Wilkins, S., Deleva, K., Lynch, T., Kok, G., Ritchie, C. W., Tanzi, R.E., Cappai, R., Masters, C. L., Barnham, K. J., and Bush, A. I.,2008,"Rapidrestoration of cognition in Alzheimer's transgenic mice with8-hydroxy quinolineanalogs is associated with decreased interstitial Abeta," Neuron,59(1), pp.43-55.
[40] Crawford, I. L., and Connor, J. D.,1972,"Zinc in maturing rat brain: hippocampalconcentration and localization," J Neurochem,19(6), pp.1451-1458.
[41] Hu, K. H., and Friede, R. L.,1968,"Topographic determination of zinc in human brainby atomic absorption spectrophotometry," J Neurochem,15(7), pp.677-685.
[42] Ding, H., Matthews, T. A., and Johnson, G. V.,2006,"Site-specific phosphorylationand caspase cleavage differentially impact tau-microtubule interactions and tauaggregation," J Biol Chem,281(28), pp.19107-19114.
[43] Rankin, C. A., Sun, Q., and Gamblin, T. C.,2005,"Pseudo-phosphorylation of tau atSer202and Thr205affects tau filament formation," Brain Res Mol Brain Res,138(1),pp.84-93.
[44] Janssens, V., and Goris, J.,2001,"Protein phosphatase2A: a highly regulated familyof serine/threonine phosphatases implicated in cell growth and signalling," Biochem J,353(Pt3), pp.417-439.
[45] Mumby, M.,2007,"PP2A: unveiling a reluctant tumor suppressor," Cell,130(1), pp.21-24.
[46] Kim, I., Park, E. J., Seo, J., Ko, S. J., Lee, J., and Kim, C. H.,2011,"Zinc stimulatestau S214phosphorylation by the activation of Raf/mitogen-activated proteinkinase-kinase/extracellular signal-regulated kinase pathway," Neuroreport,22(16), pp.839-844.
[47] An, W. L., Bjorkdahl, C., Liu, R., Cowburn, R. F., Winblad, B., and Pei, J. J.,2005,"Mechanism of zinc-induced phosphorylation of p70S6kinase and glycogen synthasekinase3beta in SH-SY5Y neuroblastoma cells," J Neurochem,92(5), pp.1104-1115.
[48] Ogris, E., Gibson, D. M., and Pallas, D. C.,1997,"Protein phosphatase2A subunitassembly: the catalytic subunit carboxy terminus is important for binding cellular Bsubunit but not polyomavirus middle tumor antigen," Oncogene,15(8), pp.911-917.
[49] Baharians, Z., and Schonthal, A. H.,1998,"Autoregulation of protein phosphatasetype2A expression," J Biol Chem,273(30), pp.19019-19024.
[50] Green, D. D., Yang, S. I., and Mumby, M. C.,1987,"Molecular cloning and sequenceanalysis of the catalytic subunit of bovine type2A protein phosphatase," Proc NatlAcad Sci U S A,84(14), pp.4880-4884.
[51] Findik, D., and Presek, P.,1988,"Zn2+enhances protein tyrosine kinase activity ofhuman platelet membranes," Febs Lett,235(1-2), pp.51-56.
[52] Manzerra, P., Behrens, M. M., Canzoniero, L. M., Wang, X. Q., Heidinger, V.,Ichinose, T., Yu, S. P., and Choi, D. W.,2001,"Zinc induces a Src familykinase-mediated up-regulation of NMDA receptor activity and excitotoxicity," ProcNatl Acad Sci U S A,98(20), pp.11055-11061.
[53] Kim, T. Y., Hwang, J. J., Yun, S. H., Jung, M. W., and Koh, J. Y.,2002,"Augmentation by zinc of NMDA receptor-mediated synaptic responses in CA1of rathippocampal slices: mediation by Src family tyrosine kinases," Synapse,46(2), pp.49-56.
[54] Liao, S. L., Ou, Y. C., Lin, S. Y., Kao, T. K., Pan, H. C., Chang, C. Y., Lai, C. Y., Lu,H. C., Wang, W. Y., and Chen, C. J.,2011,"Signaling cascades mediate astrocytedeath induced by zinc," Toxicol Lett,204(2-3), pp.108-117.
[1].Gong, C.X., et al., Phosphatase activity toward abnormally phosphorylated tau:decrease in Alzheimer disease brain. J Neurochem,1995.65(2): p.732-8.
[2].Liu, F., et al., Contributions of protein phosphatases PP1, PP2A, PP2B and PP5to theregulation of tau phosphorylation. Eur J Neurosci,2005.22(8): p.1942-50.
[3].Wang, J.Z., et al., Dephosphorylation of Alzheimer paired helical filaments by proteinphosphatase-2A and-2B. J Biol Chem,1995.270(9): p.4854-60.
[4].Cai, L., et al., A metal-dependent form of protein phosphatase2A. Biochem BiophysRes Commun,1995.208(1): p.274-9.
[5].Galadari, S., A. Hago and M. Patel, Effects of cations on ceramide-activated proteinphosphatase2A. Exp Mol Med,2001.33(4): p.240-4.
[6].Goldberg, J., et al., Three-dimensional structure of the catalytic subunit of proteinserine/threonine phosphatase-1. Nature,1995.376(6543): p.745-53.
[7].Sun, X.Y., et al., Synaptic released zinc promotes tau hyperphosphorylation byinhibition of protein phosphatase2A (PP2A). J Biol Chem,2012.287(14): p.11174-82.
[8].Xiong, Y., et al., Zinc induces protein phosphatase2A inactivation and tauhyperphosphorylation through Src dependent PP2A (tyrosine307) phosphorylation.Neurobiol Aging,2013.34(3): p.745-56.
[9].Haase, H. and W. Maret, Intracellular zinc fluctuations modulate protein tyrosinephosphatase activity in insulin/insulin-like growth factor-1signaling. Exp Cell Res,2003.291(2): p.289-98.
[10].Yuan, H., et al., The serine protease plasmin cleaves the amino-terminal domain of theNR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors. J BiolChem,2009.284(19): p.12862-73.
[11].Goldberg, J., et al., Three-dimensional structure of the catalytic subunit of proteinserine/threonine phosphatase-1. Nature,1995.376(6543): p.745-53.
[12].Fellner, T., et al., A novel and essential mechanism determining specificity andactivity of protein phosphatase2A (PP2A) in vivo. Genes Dev,2003.17(17): p.2138-50.
[13].Janssens, V. and J. Goris, Protein phosphatase2A: a highly regulated family ofserine/threonine phosphatases implicated in cell growth and signalling. Biochem J,2001.353(Pt3): p.417-39.
[14].Goldberg, Y., Protein phosphatase2A: who shall regulate the regulator? BiochemPharmacol,1999.57(4): p.321-8.
[15].Li, M., A. Makkinje and Z. Damuni, The myeloid leukemia-associated protein SET isa potent inhibitor of protein phosphatase2A. J Biol Chem,1996.271(19): p.11059-62.
[16].Li, M., H. Guo and Z. Damuni, Purification and characterization of two potentheat-stable protein inhibitors of protein phosphatase2A from bovine kidney.Biochemistry,1995.34(6): p.1988-96.
[17].Cohen, P.T., Novel protein serine/threonine phosphatases: variety is the spice of life.Trends Biochem Sci,1997.22(7): p.245-51.
[18].Liu, R., et al., Phosphorylated PP2A (tyrosine307) is associated with Alzheimerneurofibrillary pathology. J Cell Mol Med,2008.12(1): p.241-57.
[19].King, M.M. and C.Y. Huang, The calmodulin-dependent activation and deactivationof the phosphoprotein phosphatase, calcineurin, and the effect of nucleotides,pyrophosphate, and divalent metal ions. Identification of calcineurin as a Zn and Femetalloenzyme. J Biol Chem,1984.259(14): p.8847-56.
[20].Zhuo, S. and J.E. Dixon, Effects of sulfhydryl regents on the activity of lambdaSer/Thr phosphoprotein phosphatase and inhibition of the enzyme by zinc ion. ProteinEng,1997.10(12): p.1445-52.
[21].Wang, J.Z., I. Grundke-Iqbal and K. Iqbal, Restoration of biological activity ofAlzheimer abnormally phosphorylated tau by dephosphorylation with proteinphosphatase-2A,-2B and-1. Brain Res Mol Brain Res,1996.38(2): p.200-8.
[22].Fernandez, J.J., et al., Okadaic acid, useful tool for studying cellular processes. CurrMed Chem,2002.9(2): p.229-62.
[23].Goldberg, J., et al., Three-dimensional structure of the catalytic subunit of proteinserine/threonine phosphatase-1. Nature,1995.376(6543): p.745-53.
[1] Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. BrainRes1982;239(1):57-69.
[2] Koh JY, Suh SW, Gwag BJ, He YY, Hsu CY, Choi DW. The role of zinc in selectiveneuronal death after transient global cerebral ischemia. Science1996;272(5264):1013-6.
[3] Kusakawa G, Saito T, Onuki R, Ishiguro K, Kishimoto T, Hisanaga S.Calpain-dependent proteolytic cleavage of the p35cyclin-dependent kinase5activatorto p25. J Biol Chem2000;275(22):17166-72.
[4] Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. Neurotoxicity inducescleavage of p35to p25by calpain. Nature2000;405(6784):360-4.
[5] Nath R, Davis M, Probert AW, Kupina NC, Ren X, Schielke GP, Wang KK.Processing of cdk5activator p35to its truncated form (p25) by calpain in acutelyinjured neuronal cells. Biochem Biophys Res Commun2000;274(1):16-21.
[6] Wang J, Liu S, Fu Y, Wang JH, Lu Y. Cdk5activation induces hippocampal CA1celldeath by directly phosphorylating NMDA receptors. Nat Neurosci2003;6(10):1039-47.
[7] Weishaupt JH, Kussmaul L, Grotsch P, Heckel A, Rohde G, Romig H, Bahr M,Gillardon F. Inhibition of CDK5is protective in necrotic and apoptotic paradigms ofneuronal cell death and prevents mitochondrial dysfunction. Mol Cell Neurosci2003;24(2):489-502.
[1] Janssens, V., and Goris, J.,2001,"Protein phosphatase2A: a highly regulated familyof serine/threonine phosphatases implicated in cell growth and signalling," Biochem J,353(Pt3), pp.417-439.
[2] Goldberg, Y.,1999,"Protein phosphatase2A: who shall regulate the regulator?"Biochem Pharmacol,57(4), pp.321-328.
[3] Van Hoof, C., and Goris, J.,2003,"Phosphatases in apoptosis: to be or not to be,PP2A is in the heart of the question," Biochim Biophys Acta,1640(2-3), pp.97-104.
[4] Flegg, C. P., Sharma, M., Medina-Palazon, C., Jamieson, C., Galea, M., Brocardo, M.G., Mills, K., and Henderson, B. R.,2010,"Nuclear export and centrosome targetingof the protein phosphatase2A subunit B56alpha: role of B56alpha in nuclear export ofthe catalytic subunit," J Biol Chem,285(24), pp.18144-18154.
[5] Agostinis, P., Derua, R., Sarno, S., Goris, J., and Merlevede, W.,1992,"Specificity ofthe polycation-stimulated (type-2A) and ATP,Mg-dependent (type-1) proteinphosphatases toward substrates phosphorylated by P34cdc2kinase," Eur J Biochem,205(1), pp.241-248.
[6] Mumby, M. C., Russell, K. L., Garrard, L. J., and Green, D. D.,1987,"Cardiaccontractile protein phosphatases. Purification of two enzyme forms and theircharacterization with subunit-specific antibodies," J Biol Chem,262(13), pp.6257-6265.
[7] Imaoka, T., Imazu, M., Usui, H., Kinohara, N., and Takeda, M.,1983,"Resolution andreassociation of three distinct components from pig heart phosphoproteinphosphatase," J Biol Chem,258(3), pp.1526-1535.
[8] Turowski, P., Myles, T., Hemmings, B. A., Fernandez, A., and Lamb, N. J.,1999,"Vimentin dephosphorylation by protein phosphatase2A is modulated by the targetingsubunit B55," Mol Biol Cell,10(6), pp.1997-2015.
[9] Mayer-Jaekel, R. E., Ohkura, H., Ferrigno, P., Andjelkovic, N., Shiomi, K., Uemura,T., Glover, D. M., and Hemmings, B. A.,1994,"Drosophila mutants in the55kDaregulatory subunit of protein phosphatase2A show strongly reduced ability todephosphorylate substrates of p34cdc2," J Cell Sci,107(Pt9), pp.2609-2616.
[10] Chen, J., Martin, B. L., and Brautigan, D. L.,1992,"Regulation of proteinserine-threonine phosphatase type-2A by tyrosine phosphorylation," Science,257(5074), pp.1261-1264.
[11] Takai, A., and Mieskes, G.,1991,"Inhibitory effect of okadaic acid on thep-nitrophenyl phosphate phosphatase activity of protein phosphatases," Biochem J,275(Pt1), pp.233-239.
[12] Xiong, Y., Jing, X. P., Zhou, X. W., Wang, X. L., Yang, Y., Sun, X. Y., Qiu, M., Cao,F. Y., Lu, Y. M., Liu, R., and Wang, J. Z.,2013,"Zinc induces protein phosphatase2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine307) phosphorylation," Neurobiol Aging,34(3), pp.745-756.
[13] Sun, X. Y., Wei, Y. P., Xiong, Y., Wang, X. C., Xie, A. J., Wang, X. L., Yang, Y.,Wang, Q., Lu, Y. M., Wang, J. Z., and Liu, R.,2012,"Synaptic released zinc promotestau hyperphosphorylation by inhibition of PP2A," J Biol Chem.
[14] Qi, Z., Yang, W., Liu, Y., Cui, T., Gao, H., Duan, C., Lu, L., Zhao, C., Zhao, H., andYang, H.,2011,"Loss of PINK1function decreases PP2A activity and promotesautophagy in dopaminergic cells and a murine model," Neurochem Int,59(5), pp.572-581.
[15] Lee, J., and Stock, J.,1993,"Protein phosphatase2A catalytic subunit ismethyl-esterified at its carboxyl terminus by a novel methyltransferase," J Biol Chem,268(26), pp.19192-19195.
[16] Xie, H., and Clarke, S.,1994,"Protein phosphatase2A is reversibly modified bymethyl esterification at its C-terminal leucine residue in bovine brain," J Biol Chem,269(3), pp.1981-1984.
[17] De Baere, I., Derua, R., Janssens, V., Van Hoof, C., Waelkens, E., Merlevede, W., andGoris, J.,1999,"Purification of porcine brain protein phosphatase2A leucine carboxylmethyltransferase and cloning of the human homologue," Biochemistry-Us,38(50), pp.16539-16547.
[18] Lee, J., and Stock, J.,1993,"Protein phosphatase2A catalytic subunit ismethyl-esterified at its carboxyl terminus by a novel methyltransferase," J Biol Chem,268(26), pp.19192-19195.
[19] Sontag, J. M., Nunbhakdi-Craig, V., Mitterhuber, M., Ogris, E., and Sontag, E.,2010,"Regulation of protein phosphatase2A methylation by LCMT1and PME-1plays acritical role in differentiation of neuroblastoma cells," J Neurochem,115(6), pp.1455-1465.
[20] Lee, J., Chen, Y., Tolstykh, T., and Stock, J.,1996,"A specific protein carboxylmethylesterase that demethylates phosphoprotein phosphatase2A in bovine brain,"Proc Natl Acad Sci U S A,93(12), pp.6043-6047.
[21] Wu, J., Tolstykh, T., Lee, J., Boyd, K., Stock, J. B., and Broach, J. R.,2000,"Carboxyl methylation of the phosphoprotein phosphatase2A catalytic subunitpromotes its functional association with regulatory subunits in vivo," Embo J,19(21),pp.5672-5681.
[22] Xu, Y., Xing, Y., Chen, Y., Chao, Y., Lin, Z., Fan, E., Yu, J. W., Strack, S., Jeffrey, P.D., and Shi, Y.,2006,"Structure of the protein phosphatase2A holoenzyme," Cell,127(6), pp.1239-1251.
[23] Xu, Y., Chen, Y., Zhang, P., Jeffrey, P. D., and Shi, Y.,2008,"Structure of a proteinphosphatase2A holoenzyme: insights into B55-mediated Tau dephosphorylation,"Mol Cell,31(6), pp.873-885.
[24] Longin, S., Zwaenepoel, K., Martens, E., Louis, J. V., Rondelez, E., Goris, J., andJanssens, V.,2008,"Spatial control of protein phosphatase2A (de)methylation," ExpCell Res,314(1), pp.68-81.
[25] Longin, S., Zwaenepoel, K., Louis, J. V., Dilworth, S., Goris, J., and Janssens, V.,2007,"Selection of protein phosphatase2A regulatory subunits is mediated by the Cterminus of the catalytic Subunit," J Biol Chem,282(37), pp.26971-26980.
[26] Shi, Y.,2009,"Serine/threonine phosphatases: mechanism through structure," Cell,139(3), pp.468-484.
[27] Xing, Y., Li, Z., Chen, Y., Stock, J. B., Jeffrey, P. D., and Shi, Y.,2008,"Structuralmechanism of demethylation and inactivation of protein phosphatase2A," Cell,133(1),pp.154-163.
[28] Hombauer, H., Weismann, D., Mudrak, I., Stanzel, C., Fellner, T., Lackner, D. H., andOgris, E.,2007,"Generation of active protein phosphatase2A is coupled toholoenzyme assembly," PLoS Biol,5(6), p. e155.
[29] Li, M., Guo, H., and Damuni, Z.,1995,"Purification and characterization of twopotent heat-stable protein inhibitors of protein phosphatase2A from bovine kidney,"Biochemistry-Us,34(6), pp.1988-1996.
[30] Li, M., Makkinje, A., and Damuni, Z.,1996,"The myeloid leukemia-associatedprotein SET is a potent inhibitor of protein phosphatase2A," J Biol Chem,271(19), pp.11059-11062.
[31] Guo, H., and Damuni, Z.,1993,"Autophosphorylation-activated protein kinasephosphorylates and inactivates protein phosphatase2A," Proc Natl Acad Sci U S A,90(6), pp.2500-2504.
[32] Junttila, M. R., Puustinen, P., Niemela, M., Ahola, R., Arnold, H., Bottzauw, T.,Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., Lu, S. L., Lin, S., Chan, E. K., Wang, X.J., Grenman, R., Kast, J., Kallunki, T., Sears, R., Kahari, V. M., and Westermarck, J.,2007,"CIP2A inhibits PP2A in human malignancies," Cell,130(1), pp.51-62.
[33] Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W.C., Stukenberg, P. T., Shenolikar, S., Uchida, T., Counter, C. M., Nevins, J. R., Means,A. R., and Sears, R.,2004,"A signalling pathway controlling c-Myc degradation thatimpacts oncogenic transformation of human cells," Nat Cell Biol,6(4), pp.308-318.
[34] Arnold, H. K., and Sears, R. C.,2006,"Protein phosphatase2A regulatory subunitB56alpha associates with c-myc and negatively regulates c-myc accumulation," MolCell Biol,26(7), pp.2832-2844.
[35] Chao, Y., Xing, Y., Chen, Y., Xu, Y., Lin, Z., Li, Z., Jeffrey, P. D., Stock, J. B., andShi, Y.,2006,"Structure and mechanism of the phosphotyrosyl phosphataseactivator," Mol Cell,23(4), pp.535-546.
[36] Schild, A., Ittner, L. M., and Gotz, J.,2006,"Altered phosphorylation of cytoskeletalproteins in mutant protein phosphatase2A transgenic mice," Biochem Biophys ResCommun,343(4), pp.1171-1178.
[37] Holm, L., and Sander, C.,1993,"Protein structure comparison by alignment ofdistance matrices," J Mol Biol,233(1), pp.123-138.
[38] Fellner, T., Lackner, D. H., Hombauer, H., Piribauer, P., Mudrak, I., Zaragoza, K.,Juno, C., and Ogris, E.,2003,"A novel and essential mechanism determiningspecificity and activity of protein phosphatase2A (PP2A) in vivo," Genes Dev,17(17),pp.2138-2150.
[39] Luo, Y., Nie, Y. J., Shi, H. R., Ni, Z. F., Wang, Q., Wang, J. Z., and Liu, G. P.,2013,"PTPA activates protein phosphatase-2A through reducing its phosphorylation attyrosine-307with upregulation of protein tyrosine phosphatase1B," Biochim BiophysActa,1833(5), pp.1235-1243.
[40] Cai, L., Chu, Y., Wilson, S. E., and Schlender, K. K.,1995,"A metal-dependent formof protein phosphatase2A," Biochem Biophys Res Commun,208(1), pp.274-279.
[41] Yu, J. S.,1998,"Activation of protein phosphatase2A by the Fe2+/ascorbate system,"J Biochem,124(1), pp.225-230.
[42] Galadari, S., Hago, A., and Patel, M.,2001,"Effects of cations on ceramide-activatedprotein phosphatase2A," Exp Mol Med,33(4), pp.240-244.
[43] Wozniak, E., Oldziej, S., and Ciarkowski, J.,2000,"Molecular modeling of thecatalytic domain of serine/threonine phosphatase-1with the Zn2+and Mn2+di-nuclear ion centers in the active site," Comput Chem,24(3-4), pp.381-390.
[44] Wirt, S. E., and Sage, J.,2010,"p107in the public eye: an Rb understudy and more,"Cell Div,5, p.9.
[45] Garriga, J., Jayaraman, A. L., Limon, A., Jayadeva, G., Sotillo, E., Truongcao, M.,Patsialou, A., Wadzinski, B. E., and Grana, X.,2004,"A dynamic equilibriumbetween CDKs and PP2A modulates phosphorylation of pRB, p107and p130," CellCycle,3(10), pp.1320-1330.
[46] Kurimchak, A., and Grana, X.,2012,"PP2A holoenzymes negatively and positivelyregulate cell cycle progression by dephosphorylating pocket proteins and multipleCDK substrates," Gene,499(1), pp.1-7.
[47] Zolnierowicz, S.,2000,"Type2A protein phosphatase, the complex regulator ofnumerous signaling pathways," Biochem Pharmacol,60(8), pp.1225-1235.
[48] Gould, K. L., Moreno, S., Owen, D. J., Sazer, S., and Nurse, P.,1991,"Phosphorylation at Thr167is required for Schizosaccharomyces pombe p34cdc2function," Embo J,10(11), pp.3297-3309.
[49] Kinoshita, N., Yamano, H., Niwa, H., Yoshida, T., and Yanagida, M.,1993,"Negativeregulation of mitosis by the fission yeast protein phosphatase ppa2," Genes Dev,7(6),pp.1059-1071.
[50]Krasinska, L., Domingo-Sananes, M. R., Kapuy, O., Parisis, N., Harker, B., Moorhead,G., Rossignol, M., Novak, B., and Fisher, D.,2011,"Protein phosphatase2A controlsthe order and dynamics of cell-cycle transitions," Mol Cell,44(3), pp.437-450.
[51] Lindqvist, A., Rodriguez-Bravo, V., and Medema, R. H.,2009,"The decision to entermitosis: feedback and redundancy in the mitotic entry network," J Cell Biol,185(2),pp.193-202.
[52] Clarke, P. R., Hoffmann, I., Draetta, G., and Karsenti, E.,1993,"Dephosphorylation ofcdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle inXenopus egg extracts," Mol Biol Cell,4(4), pp.397-411.
[53] Blagosklonny, M. V.,2001,"Unwinding the loop of Bcl-2phosphorylation,"Leukemia,15(6), pp.869-874.
[54] Deng, X., Ruvolo, P., Carr, B., and May, W. J.,2000,"Survival function of ERK1/2asIL-3-activated, staurosporine-resistant Bcl2kinases," Proc Natl Acad Sci U S A,97(4),pp.1578-1583.
[55] Ruvolo, P. P., Deng, X., Carr, B. K., and May, W. S.,1998,"A functional role formitochondrial protein kinase Calpha in Bcl2phosphorylation and suppression ofapoptosis," J Biol Chem,273(39), pp.25436-25442.
[56] Muscarella, D. E., and Bloom, S. E.,2008,"The contribution of c-Jun N-terminalkinase activation and subsequent Bcl-2phosphorylation to apoptosis induction inhuman B-cells is dependent on the mode of action of specific stresses," Toxicol ApplPharmacol,228(1), pp.93-104.
[57] Deng, X., Ito, T., Carr, B., Mumby, M., and May, W. J.,1998,"Reversiblephosphorylation of Bcl2following interleukin3or bryostatin1is mediated by directinteraction with protein phosphatase2A," J Biol Chem,273(51), pp.34157-34163.
[58] Ruvolo, P. P., Deng, X., Ito, T., Carr, B. K., and May, W. S.,1999,"Ceramide inducesBcl2dephosphorylation via a mechanism involving mitochondrial PP2A," J BiolChem,274(29), pp.20296-20300.
[59] Van Hoof, C., and Goris, J.,2003,"Phosphatases in apoptosis: to be or not to be,PP2A is in the heart of the question," Biochim Biophys Acta,1640(2-3), pp.97-104.
[60] Lv, X., Wan, J., Yang, J., Cheng, H., Li, Y., Ao, Y., and Peng, R.,2008,"CytochromeP450omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activationof ERK1/2signaling in rat myocardial ischemia-reperfusion," Eur J Pharmacol,596(1-3), pp.118-126.
[61] Chang, H., Lin, H., Yi, L., Zhu, J., Zhou, Y., Mi, M., and Zhang, Q.,2010,"3,6-Dihydroxyflavone induces apoptosis in leukemia HL-60cell via reactive oxygenspecies-mediated p38MAPK/JNK pathway," Eur J Pharmacol,648(1-3), pp.31-38.
[62] Liu, G. P., Wei, W., Zhou, X., Zhang, Y., Shi, H. H., Yin, J., Yao, X. Q., Peng, C. X.,Hu, J., Wang, Q., Li, H. L., and Wang, J. Z.,2012,"I(2)(PP2A) regulates p53and Aktcorrelatively and leads the neurons to abort apoptosis," Neurobiol Aging,33(2), pp.254-264.
[63] Klionsky, D. J.,2008,"Autophagy revisited: a conversation with Christian de Duve,"Autophagy,4(6), pp.740-743.
[64] Mizushima, N., and Komatsu, M.,2011,"Autophagy: renovation of cells and tissues,"Cell,147(4), pp.728-741.
[65] Chen, Y., and Klionsky, D. J.,2011,"The regulation of autophagy-unansweredquestions," J Cell Sci,124(Pt2), pp.161-170.
[66] Mizushima, N., Yoshimori, T., and Ohsumi, Y.,2011,"The role of Atg proteins inautophagosome formation," Annu Rev Cell Dev Biol,27, pp.107-132.
[67] Nakatogawa, H., Suzuki, K., Kamada, Y., and Ohsumi, Y.,2009,"Dynamics anddiversity in autophagy mechanisms: lessons from yeast," Nat Rev Mol Cell Biol,10(7),pp.458-467.
[68] Holen, I., Gordon, P. B., and Seglen, P. O.,1993,"Inhibition of hepatocytic autophagyby okadaic acid and other protein phosphatase inhibitors," Eur J Biochem,215(1), pp.113-122.
[69] Zaman, S., Lippman, S. I., Zhao, X., and Broach, J. R.,2008,"How Saccharomycesresponds to nutrients," Annu Rev Genet,42, pp.27-81.
[70] Zabrocki, P., Van Hoof, C., Goris, J., Thevelein, J. M., Winderickx, J., and Wera, S.,2002,"Protein phosphatase2A on track for nutrient-induced signalling in yeast," MolMicrobiol,43(4), pp.835-842.
[71] Maiuri, M. C., Tasdemir, E., Criollo, A., Morselli, E., Vicencio, J. M., Carnuccio, R.,and Kroemer, G.,2009,"Control of autophagy by oncogenes and tumor suppressorgenes," Cell Death Differ,16(1), pp.87-93.
[72] Banreti, A., Lukacsovich, T., Csikos, G., Erdelyi, M., and Sass, M.,2012,"PP2Aregulates autophagy in two alternative ways in Drosophila," Autophagy,8(4), pp.623-636.
[73] Ogura, K., Okada, T., Mitani, S., Gengyo-Ando, K., Baillie, D. L., Kohara, Y., andGoshima, Y.,2010,"Protein phosphatase2A cooperates with the autophagy-relatedkinase UNC-51to regulate axon guidance in Caenorhabditis elegans," Development,137(10), pp.1657-1667.
[74] He, C., and Klionsky, D. J.,2009,"Regulation mechanisms and signaling pathways ofautophagy," Annu Rev Genet,43, pp.67-93.
[75] Potter, C. J., Pedraza, L. G., and Xu, T.,2002,"Akt regulates growth by directlyphosphorylating Tsc2," Nat Cell Biol,4(9), pp.658-665.
[76] Vereshchagina, N., Ramel, M. C., Bitoun, E., and Wilson, C.,2008,"The proteinphosphatase PP2A-B' subunit Widerborst is a negative regulator of cytoplasmicactivated Akt and lipid metabolism in Drosophila," J Cell Sci,121(Pt20), pp.3383-3392.
[77] Potter, C. J., Huang, H., and Xu, T.,2001,"Drosophila Tsc1functions with Tsc2toantagonize insulin signaling in regulating cell growth, cell proliferation, and organsize," Cell,105(3), pp.357-368.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |